|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23562926 |
|
NCBI chrNW_004936763:1,225,355...1,308,257
Ensembl chrNW_004936763:1,226,482...1,297,427
|
|
G |
Ache |
acetylcholinesterase (Cartwright blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17098105 PMID:19453088 |
RGD:5688054 |
NCBI chrNW_004936543:856,678...862,080
Ensembl chrNW_004936543:856,676...862,109
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20176007 PMID:20513442 PMID:21620937 PMID:21683774 PMID:29183815 |
|
NCBI chrNW_004936707:1,784,338...1,913,401
Ensembl chrNW_004936707:1,854,444...1,913,460
|
|
G |
Cdkn2b |
cyclin dependent kinase inhibitor 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20044985 |
|
NCBI chrNW_004936652:3,576,975...3,582,790
Ensembl chrNW_004936652:3,538,986...3,581,159
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15727166 |
|
NCBI chrNW_004936490:15,142,526...15,146,375
Ensembl chrNW_004936490:15,142,808...15,144,487
|
|
G |
Epo |
erythropoietin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15727166 |
|
NCBI chrNW_004936543:742,722...745,332
Ensembl chrNW_004936543:743,537...745,343
|
|
G |
Gcg |
glucagon |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7629900 |
|
NCBI chrNW_004936469:16,906,658...16,916,045
Ensembl chrNW_004936469:16,906,658...16,916,045
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22975441 |
|
NCBI chrNW_004936536:6,730,070...6,893,818
Ensembl chrNW_004936536:6,730,062...6,894,303
|
|
G |
Hand1 |
heart and neural crest derivatives expressed 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21964422 |
|
NCBI chrNW_004936515:8,289,764...8,292,937
Ensembl chrNW_004936515:8,289,315...8,293,175
|
|
G |
Il1a |
interleukin 1 alpha |
treatment |
ISO |
|
RGD |
PMID:1868253 PMID:2258610 |
RGD:11051971 RGD:11059514 |
NCBI chrNW_004936783:1,210,715...1,218,315
Ensembl chrNW_004936783:1,210,809...1,218,315
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
|
ISO |
ClinVar Annotator: match by term: Benzene toxicity, susceptibility to |
ClinVar |
PMID:1737339 PMID:6933553 PMID:9000600 PMID:9230185 PMID:9328142 PMID:9593466 PMID:9855009 PMID:10393869 PMID:10393963 PMID:18511948 More...
|
|
NCBI chrNW_004936475:19,771,384...19,785,034
Ensembl chrNW_004936475:19,769,488...19,785,311
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20036648 |
|
NCBI chrNW_004936590:4,722,914...4,887,615
Ensembl chrNW_004936590:4,722,873...4,890,156
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:22525860 |
|
NCBI chrNW_004936489:11,605,403...11,627,786
Ensembl chrNW_004936489:11,594,480...11,627,786
|
|
G |
Xirp1 |
xin actin binding repeat containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21964422 |
|
NCBI chrNW_004936473:28,434,910...28,444,146
Ensembl chrNW_004936473:28,436,996...28,444,176
|
|
|
G |
Cck |
cholecystokinin |
susceptibility |
ISO |
DNA:SNP:promoter: -45C>T (human) |
RGD |
PMID:10235270 |
RGD:406351024 |
NCBI chrNW_004936695:2,776,705...2,782,280
Ensembl chrNW_004936695:2,776,831...2,782,061
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
|
RGD |
PMID:11841893 |
RGD:1626329 |
NCBI chrNW_004936510:3,779,930...3,806,615
Ensembl chrNW_004936510:3,781,210...3,802,693
|
|
G |
Ngf |
nerve growth factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:17434673 |
RGD:401965399 |
NCBI chrNW_004936627:635,784...641,290
Ensembl chrNW_004936627:635,788...645,364
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:16318954 |
RGD:5688289 |
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27219321 |
|
NCBI chrNW_004936815:359,775...400,690
Ensembl chrNW_004936815:359,775...400,690
|
|
|
G |
Cacna1d |
calcium voltage-gated channel subunit alpha1 D |
susceptibility |
ISO |
mRNA, protein:increased expression:inferior colliculus (rat) |
RGD |
PMID:25556199 |
RGD:152985539 |
NCBI chrNW_004936473:4,164,633...4,479,866
Ensembl chrNW_004936473:4,037,533...4,478,073
|
|
G |
Drd2 |
dopamine receptor D2 |
susceptibility |
ISO |
DNA:SNP:exon:A>G(human) |
RGD |
PMID:23238469 |
RGD:401959213 |
NCBI chrNW_004936612:1,094,686...1,154,149
Ensembl chrNW_004936612:1,094,680...1,154,798
|
|
G |
Pdyn |
prodynorphin |
|
ISO |
mRNA:increased expression:brain |
RGD |
PMID:15869750 |
RGD:401850576 |
NCBI chrNW_004936485:16,559,371...16,571,461
Ensembl chrNW_004936485:16,559,217...16,571,678
|
|
G |
Slc29a1 |
solute carrier family 29 member 1 (Augustine blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21283641 |
|
NCBI chrNW_004936476:15,849,054...15,862,486
Ensembl chrNW_004936476:15,846,606...15,862,548
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27219321 |
|
NCBI chrNW_004936815:359,775...400,690
Ensembl chrNW_004936815:359,775...400,690
|
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
ISO |
protein:increased expression:cortex, hippocampus (rat) |
RGD |
PMID:18585922 |
RGD:2313030 |
NCBI chrNW_004936727:1,907,493...1,909,350
Ensembl chrNW_004936727:1,907,505...1,909,338
|
|
G |
Cirbp |
cold inducible RNA binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24223948 |
|
NCBI chrNW_004936588:636,041...639,564
Ensembl chrNW_004936588:636,026...640,409
|
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26711020 |
|
NCBI chrNW_004936558:4,362,693...4,387,705
Ensembl chrNW_004936558:4,362,654...4,390,414
|
|
G |
Ankk1 |
ankyrin repeat and kinase domain containing 1 |
|
ISO |
DNA:SNP:exon:rs1800497(human) |
RGD |
PMID:18669994 |
RGD:401959336 |
NCBI chrNW_004936612:1,161,961...1,173,318
|
|
G |
Drd2 |
dopamine receptor D2 |
|
ISO |
DNA:SNP:cds:957C>T(human) |
RGD |
PMID:18669994 |
RGD:401959336 |
NCBI chrNW_004936612:1,094,686...1,154,149
Ensembl chrNW_004936612:1,094,680...1,154,798
|
|
G |
Foxo4 |
forkhead box O4 |
|
ISO |
protein:increased phosphorylation:small intestine: |
RGD |
PMID:23292333 |
RGD:10402360 |
NCBI chrNW_004936762:495,271...501,278
Ensembl chrNW_004936762:493,910...501,531
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
ISO |
|
RGD |
PMID:24972622 |
RGD:10401897 |
NCBI chrNW_004936792:531,076...579,083
Ensembl chrNW_004936792:531,756...579,166
|
|
G |
Hectd4 |
HECT domain E3 ubiquitin protein ligase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35713687 |
|
NCBI chrNW_004936668:2,390,902...2,514,653
Ensembl chrNW_004936668:2,390,405...2,514,708
|
|
|
G |
Ank3 |
ankyrin 3 |
|
ISO |
DNA:SNP:CDS:rs7917190 |
RGD |
PMID:29109170 |
RGD:597830079 |
NCBI chrNW_004936614:2,664,594...2,976,174
|
|
G |
Arhgef10 |
Rho guanine nucleotide exchange factor 10 |
|
ISO |
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274 |
RGD |
PMID:31372216 |
RGD:597830081 |
NCBI chrNW_004936615:1,012,009...1,103,468
Ensembl chrNW_004936615:1,048,536...1,102,242
|
|
G |
Rps6ka1 |
ribosomal protein S6 kinase A1 |
|
ISO |
DNA:SNP:CDS:rs4659444 |
RGD |
PMID:29109170 |
RGD:597830079 |
NCBI chrNW_004936474:10,996,867...11,030,504
Ensembl chrNW_004936474:10,996,813...11,030,557
|
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
|
RGD |
PMID:23016131 |
RGD:10402569 |
NCBI chrNW_004936492:11,709,623...11,784,028
Ensembl chrNW_004936492:11,709,222...11,778,351
|
|
G |
Igf1r |
insulin like growth factor 1 receptor |
|
ISO |
|
RGD |
PMID:23016131 |
RGD:10402569 |
NCBI chrNW_004936483:4,563,995...4,860,231
Ensembl chrNW_004936483:4,564,512...4,852,925
|
|
G |
Igf2 |
insulin like growth factor 2 |
|
ISO |
|
RGD |
PMID:23016131 |
RGD:10402569 |
NCBI chrNW_004936816:972,902...981,232
Ensembl chrNW_004936816:972,282...979,167
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3 group C member 1 |
treatment |
ISO |
|
RGD |
PMID:18093169 |
RGD:408345248 |
NCBI chrNW_004936504:10,960,069...11,056,834
Ensembl chrNW_004936504:10,959,192...11,056,856
|
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
|
ISO |
DNA:SNP:promoter:-1438G>A |
RGD |
PMID:11842624 |
RGD:401900738 |
NCBI chrNW_004936565:335,238...394,683
Ensembl chrNW_004936565:334,393...394,715
|
|
|
G |
Akap9 |
A-kinase anchoring protein 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936621:2,247,082...2,374,407
Ensembl chrNW_004936621:2,246,179...2,374,454
|
|
G |
Alad |
aminolevulinate dehydratase |
|
ISO |
protein:decreased activity:blood (rat) |
RGD |
PMID:19022878 |
RGD:4144202 |
NCBI chrNW_004936559:226,481...237,258
Ensembl chrNW_004936559:226,424...241,684
|
|
G |
Aqp9 |
aquaporin 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19805235 |
|
NCBI chrNW_004936471:19,321,366...19,361,227
Ensembl chrNW_004936471:19,321,426...19,362,146
|
|
G |
As3mt |
arsenite methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:21447609 PMID:26366667 PMID:35226250 |
|
NCBI chrNW_004936600:3,050,946...3,069,786
Ensembl chrNW_004936600:3,051,129...3,069,690
|
|
G |
Atxn7 |
ataxin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936637:2,422,260...2,508,681
Ensembl chrNW_004936637:2,426,498...2,508,686
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936525:8,238,128...8,240,974
Ensembl chrNW_004936525:8,237,831...8,240,974
|
|
G |
Ccrl2 |
C-C motif chemokine receptor like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936596:319,841...320,911
|
|
G |
Cd44 |
CD44 molecule (IN blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936533:2,949,026...3,033,166
|
|
G |
Cd83 |
CD83 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936552:637,471...654,422
Ensembl chrNW_004936552:637,043...656,452
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
|
ISO |
protein:increased expression:skin: |
RGD |
PMID:11860939 |
RGD:8662429 |
NCBI chrNW_004936476:22,717,308...22,725,127
Ensembl chrNW_004936476:22,717,260...22,725,182
|
|
G |
Crp |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22521605 |
|
NCBI chrNW_004936740:885,855...888,854
Ensembl chrNW_004936740:883,272...890,606
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12569548 |
|
NCBI chrNW_004936706:1,854,938...1,867,521
Ensembl chrNW_004936706:1,852,359...1,867,745
|
|
G |
Ercc3 |
ERCC excision repair 3, TFIIH core complex helicase subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12569548 |
|
NCBI chrNW_004936469:43,970,002...43,998,279
Ensembl chrNW_004936469:43,969,740...43,998,448
|
|
G |
Ercc4 |
ERCC excision repair 4, endonuclease catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12569548 |
|
NCBI chrNW_004936501:2,301,072...2,329,346
Ensembl chrNW_004936501:2,300,835...2,329,351
|
|
G |
Gadd45b |
growth arrest and DNA damage inducible beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936588:1,476,580...1,479,444
Ensembl chrNW_004936588:1,477,476...1,479,457
|
|
G |
Golga4 |
golgin A4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936473:26,741,548...26,838,342
Ensembl chrNW_004936473:26,741,858...26,838,382
|
|
G |
Gsr |
glutathione-disulfide reductase |
|
ISO |
|
RGD |
PMID:25209654 |
RGD:10401880 |
NCBI chrNW_004936792:531,076...579,083
Ensembl chrNW_004936792:531,756...579,166
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936532:5,236,175...5,238,689
Ensembl chrNW_004936532:5,236,037...5,238,881
|
|
G |
Ier3 |
immediate early response 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936837:401,475...402,769
Ensembl chrNW_004936837:401,524...402,741
|
|
G |
Igf2bp2 |
insulin like growth factor 2 mRNA binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35226250 |
|
NCBI chrNW_004936578:4,070,997...4,222,661
Ensembl chrNW_004936578:4,070,955...4,222,427
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936783:1,210,715...1,218,315
Ensembl chrNW_004936783:1,210,809...1,218,315
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
|
|
G |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25759212 |
|
NCBI chrNW_004936486:18,893,958...19,022,450
Ensembl chrNW_004936486:18,893,909...19,022,477
|
|
G |
Kcnj2 |
potassium inwardly rectifying channel subfamily J member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936655:3,447,026...3,459,569
Ensembl chrNW_004936655:3,447,321...3,458,312
|
|
G |
Krt10 |
keratin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19953893 |
|
NCBI chrNW_004936490:15,783,636...15,788,605
Ensembl chrNW_004936490:15,783,618...15,788,634
|
|
G |
LOC101955831 |
heat shock 70 kDa protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936727:1,718,952...1,721,691
|
|
G |
Mettl14 |
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35226250 |
|
NCBI chrNW_004936869:568,324...589,972
Ensembl chrNW_004936869:568,840...590,269
|
|
G |
Minpp1 |
multiple inositol-polyphosphate phosphatase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936735:1,585,741...1,627,910
Ensembl chrNW_004936735:1,586,446...1,627,845
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24384392 |
|
NCBI chrNW_004936474:623,438...637,849
Ensembl chrNW_004936474:623,291...638,193
|
|
G |
N4bp2l2 |
NEDD4 binding protein 2 like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936472:27,045,052...27,134,170
|
|
G |
Ndufb8 |
NADH:ubiquinone oxidoreductase subunit B8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936600:5,122,004...5,126,776
Ensembl chrNW_004936600:5,116,423...5,129,334
|
|
G |
Nlrp3 |
NLR family pyrin domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35226250 |
|
NCBI chrNW_004936864:709,693...732,119
Ensembl chrNW_004936864:709,709...731,718
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4 group A member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936469:21,912,118...21,920,486
Ensembl chrNW_004936469:21,912,047...21,920,486
|
|
G |
Pde4b |
phosphodiesterase 4B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936591:5,152,491...5,666,728
Ensembl chrNW_004936591:5,152,441...5,573,129
|
|
G |
Peli1 |
pellino E3 ubiquitin protein ligase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936491:8,985,074...9,040,863
Ensembl chrNW_004936491:8,985,074...9,041,244
|
|
G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936484:8,356,523...8,434,529
Ensembl chrNW_004936484:8,356,487...8,434,925
|
|
G |
Pias1 |
protein inhibitor of activated STAT 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936471:27,925,153...28,055,632
Ensembl chrNW_004936471:27,925,153...28,055,632
|
|
G |
Pnp |
purine nucleoside phosphorylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18414634 |
|
NCBI chrNW_004936877:686,539...692,832
|
|
G |
Ptx3 |
pentraxin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936519:4,303,549...4,309,143
Ensembl chrNW_004936519:4,303,464...4,309,173
|
|
G |
Rfx3 |
regulatory factor X3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936503:1,506,944...1,802,256
Ensembl chrNW_004936503:1,606,742...1,800,364
|
|
G |
Rgs1 |
regulator of G protein signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936638:879,241...883,423
Ensembl chrNW_004936638:879,287...883,169
|
|
G |
Rnf20 |
ring finger protein 20 |
|
ISO |
protein:increased expression:urine (human) |
RGD |
PMID:21136906 |
RGD:9831407 |
NCBI chrNW_004936524:9,690,611...9,715,579
Ensembl chrNW_004936524:9,690,566...9,717,173
|
|
G |
Rufy3 |
RUN and FYVE domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936598:3,987,287...4,046,019
Ensembl chrNW_004936598:3,987,320...4,046,187
|
|
G |
Sfpq |
splicing factor proline and glutamine rich |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936474:17,776,490...17,791,966
|
|
G |
Skil |
SKI like proto-oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936593:2,109,414...2,132,871
Ensembl chrNW_004936593:2,109,223...2,132,882
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936489:11,178,338...11,191,601
Ensembl chrNW_004936489:11,178,015...11,191,781
|
|
G |
Sox18 |
SRY-box transcription factor 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936514:11,231,327...11,233,292
Ensembl chrNW_004936514:11,231,305...11,233,337
|
|
G |
Srp68 |
signal recognition particle 68 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936594:1,189,245...1,230,747
Ensembl chrNW_004936594:1,189,251...1,231,014
|
|
G |
Ssbp1 |
single stranded DNA binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936592:5,611,775...5,620,846
Ensembl chrNW_004936592:5,614,619...5,619,627
|
|
G |
Taf1d |
TATA-box binding protein associated factor, RNA polymerase I subunit D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936674:1,044,519...1,053,744
Ensembl chrNW_004936674:1,046,610...1,050,177
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936469:26,129,339...26,145,464
Ensembl chrNW_004936469:26,129,331...26,145,422
|
|
G |
Tnik |
TRAF2 and NCK interacting kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936593:1,166,995...1,546,253
Ensembl chrNW_004936593:1,167,395...1,540,399
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18621066 PMID:19203779 |
|
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
|
|
G |
Tra2a |
transformer 2 alpha homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936478:622,527...642,529
Ensembl chrNW_004936478:623,342...642,525
|
|
G |
Trappc10 |
trafficking protein particle complex subunit 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936500:264,716...317,419
Ensembl chrNW_004936500:264,644...329,355
|
|
G |
Ube2e1 |
ubiquitin conjugating enzyme E2 E1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936473:15,487,341...15,557,516
Ensembl chrNW_004936473:15,487,014...15,557,513
|
|
G |
Uso1 |
USO1 vesicle transport factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936598:172,360...246,565
Ensembl chrNW_004936598:172,698...246,370
|
|
G |
Usp13 |
ubiquitin specific peptidase 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936566:3,416,468...3,522,127
Ensembl chrNW_004936566:3,416,389...3,522,133
|
|
G |
Zfand6 |
zinc finger AN1-type containing 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004936471:38,063,932...38,127,190
Ensembl chrNW_004936471:38,063,981...38,127,191
|
|
G |
Znf331 |
zinc finger protein 331 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16835338 |
|
NCBI chrNW_004937055:69,281...93,924
Ensembl chrNW_004937055:67,982...74,103
|
|
|
G |
Ache |
acetylcholinesterase (Cartwright blood group) |
treatment |
ISO |
|
RGD |
PMID:27491636 |
RGD:152995409 |
NCBI chrNW_004936543:856,678...862,080
Ensembl chrNW_004936543:856,676...862,109
|
|
G |
Ada |
adenosine deaminase |
treatment |
ISO |
|
RGD |
PMID:27491636 |
RGD:152995409 |
NCBI chrNW_004936530:2,217,713...2,224,070
|
|
G |
Cpa1 |
carboxypeptidase A1 |
|
ISO |
protein:increased activity:small intestine (rat) |
RGD |
PMID:15865404 |
RGD:1578424 |
NCBI chrNW_004936579:4,897,225...4,903,409
Ensembl chrNW_004936579:4,897,225...4,903,409
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
ISO |
protein:increased activity:plasma: |
RGD |
PMID:24361405 |
RGD:9685430 |
NCBI chrNW_004936470:26,994,549...27,099,758
Ensembl chrNW_004936470:26,994,215...27,100,999
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
treatment |
ISO |
|
RGD |
PMID:24954678 |
RGD:11352769 |
NCBI chrNW_004936529:997,943...999,123
Ensembl chrNW_004936529:998,150...998,987
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20643113 |
|
NCBI chrNW_004936588:506,101...508,469
Ensembl chrNW_004936588:506,147...508,101
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
ISO |
|
RGD |
PMID:24200859 |
RGD:10401881 |
NCBI chrNW_004936792:531,076...579,083
Ensembl chrNW_004936792:531,756...579,166
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
in males;protein:increased expression, increased activity:plasma (rat) |
RGD |
PMID:19462680 |
RGD:11060270 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
LOC101966195 |
huntingtin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19845833 |
|
NCBI chrNW_004936477:20,443,101...20,577,167
Ensembl chrNW_004936477:20,443,113...20,577,071 Ensembl chrNW_004936477:20,443,113...20,577,071
|
|
G |
Mt3 |
metallothionein 3 |
|
ISO |
|
RGD |
PMID:20371971 |
RGD:6480494 |
NCBI chrNW_004936475:8,864,512...8,866,516
Ensembl chrNW_004936475:8,864,675...8,866,506
|
|
G |
Nudt1 |
nudix hydrolase 1 |
|
ISO |
|
RGD |
PMID:11817101 |
RGD:633232 |
NCBI chrNW_004936823:7,104...22,083
Ensembl chrNW_004936823:7,099...18,677
|
|
G |
Selenop |
selenoprotein P |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20643113 |
|
NCBI chrNW_004936518:155,905...166,932
|
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
|
ISO |
|
RGD |
PMID:24704181 |
RGD:151347543 |
NCBI chrNW_004936471:36,427,598...36,447,903
Ensembl chrNW_004936471:36,427,495...36,457,758
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
|
RGD |
PMID:19520142 PMID:20422170 |
RGD:4145288 RGD:4145306 |
NCBI chrNW_004936492:5,042,353...5,049,216
Ensembl chrNW_004936492:5,042,330...5,049,311
|
|
G |
Mbp |
myelin basic protein |
|
ISO |
protein:decreased expression:brain: |
RGD |
PMID:23146304 |
RGD:7327205 |
NCBI chrNW_004936616:2,082,154...2,159,028
Ensembl chrNW_004936616:2,082,099...2,159,070
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
ISO |
|
RGD |
PMID:14761684 |
RGD:13825130 |
NCBI chrNW_004936558:5,162,471...5,302,488
Ensembl chrNW_004936558:5,233,459...5,301,414
|
|
G |
Xdh |
xanthine dehydrogenase |
|
ISO |
|
RGD |
PMID:8248931 PMID:17433579 |
RGD:13209022 RGD:13210748 |
NCBI chrNW_004936493:1,762,814...1,824,501
Ensembl chrNW_004936493:1,762,869...1,823,238
|
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
ISO |
|
RGD |
PMID:25687490 |
RGD:11341810 |
NCBI chrNW_004936599:633,501...639,412
Ensembl chrNW_004936599:633,330...639,456
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15968720 |
|
NCBI chrNW_004936694:2,051,362...2,053,812
Ensembl chrNW_004936694:2,051,325...2,053,818
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
ISO |
|
RGD |
PMID:18306454 |
RGD:2312624 |
NCBI chrNW_004936529:997,943...999,123
Ensembl chrNW_004936529:998,150...998,987
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
treatment |
ISO |
|
RGD |
PMID:31018559 |
RGD:401827907 |
NCBI chrNW_004936495:8,590,225...8,593,511
Ensembl chrNW_004936495:8,590,556...8,593,367
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
treatment |
ISO |
|
RGD |
PMID:18306454 PMID:31018559 |
RGD:2312624 RGD:401827907 |
NCBI chrNW_004936647:3,904,787...3,914,223
Ensembl chrNW_004936647:3,906,113...3,913,498
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
|
RGD |
PMID:24748974 |
RGD:10755718 |
NCBI chrNW_004936492:5,042,353...5,049,216
Ensembl chrNW_004936492:5,042,330...5,049,311
|
|
G |
Ltf |
lactotransferrin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16141546 |
|
NCBI chrNW_004936596:344,287...373,788
Ensembl chrNW_004936596:344,274...373,952
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
|
RGD |
PMID:23684718 |
RGD:11035220 |
NCBI chrNW_004936475:19,771,384...19,785,034
Ensembl chrNW_004936475:19,769,488...19,785,311
|
|
G |
Ucp2 |
uncoupling protein 2 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:19104935 |
RGD:7204431 |
NCBI chrNW_004936498:3,059,700...3,066,112
Ensembl chrNW_004936498:3,059,297...3,066,197
|
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936605:3,135,977...3,190,956
Ensembl chrNW_004936605:3,136,018...3,190,948
|
|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
severity susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNP::2677G>T/A(rs2032582)(human) |
CTD RGD |
PMID:20623750 PMID:26134275 PMID:27296832 |
RGD:11041130 RGD:14700895 |
NCBI chrNW_004936763:1,225,355...1,308,257
Ensembl chrNW_004936763:1,226,482...1,297,427
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
severity |
ISO |
DNA:SNP: :rs2287616(human) |
RGD |
PMID:27293027 |
RGD:14402413 |
NCBI chrNW_004936469:10,521,576...10,599,005
Ensembl chrNW_004936469:10,521,576...10,599,005
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18466103 |
|
NCBI chrNW_004936501:3,400,971...3,467,061
Ensembl chrNW_004936501:3,401,285...3,470,460
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
susceptibility |
ISO |
DNA:polymorphism:promoter:-24C>T(human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:17241877 PMID:18381794 PMID:18466103 PMID:25196354 |
RGD:14700812 RGD:14700814 |
NCBI chrNW_004936636:292,631...341,999
Ensembl chrNW_004936636:292,709...340,393
|
|
G |
Abi1 |
abl interactor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936484:2,090,605...2,194,109
Ensembl chrNW_004936484:2,088,927...2,194,109
|
|
G |
Acox3 |
acyl-CoA oxidase 3, pristanoyl |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936477:19,696,274...19,731,338
Ensembl chrNW_004936477:19,694,555...19,731,386
|
|
G |
Acsl1 |
acyl-CoA synthetase long chain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936554:4,425,518...4,484,853
Ensembl chrNW_004936554:4,425,495...4,484,887
|
|
G |
Actb |
actin beta |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver |
CTD RGD |
PMID:22563491 PMID:25231249 |
RGD:9587759 |
NCBI chrNW_004936765:667,107...670,627
Ensembl chrNW_004936765:667,053...670,672
|
|
G |
Actn4 |
actinin alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936801:1,333,077...1,402,885
Ensembl chrNW_004936801:1,333,077...1,404,054
|
|
G |
Actr3 |
actin related protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936469:55,639,345...55,699,330
Ensembl chrNW_004936469:55,639,068...55,699,640
|
|
G |
Ada |
adenosine deaminase |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:21161045 |
RGD:5128859 |
NCBI chrNW_004936530:2,217,713...2,224,070
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24646716 |
|
NCBI chrNW_004936486:19,389,925...19,403,577
Ensembl chrNW_004936486:19,391,324...19,402,332
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20709802 |
|
NCBI chrNW_004936578:3,168,599...3,179,369
Ensembl chrNW_004936578:3,168,331...3,171,928
|
|
G |
Adipor2 |
adiponectin receptor 2 |
severity |
ISO |
associated with obesity, LPS;mRNA:decreased expression:liver (rat) |
RGD |
PMID:23838384 |
RGD:8695926 |
NCBI chrNW_004936606:1,911,104...2,007,109
Ensembl chrNW_004936606:1,948,743...2,007,163
|
|
G |
Adora2b |
adenosine A2b receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:35292334 |
|
NCBI chrNW_004936821:583,463...608,189
Ensembl chrNW_004936821:580,675...608,245
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29499335 |
|
NCBI chrNW_004936484:19,713,299...19,721,144
Ensembl chrNW_004936484:19,716,165...19,721,261
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:decreased expression:liver (rat) |
CTD RGD |
PMID:21890736 PMID:28959666 PMID:34848246 |
RGD:401794432 |
NCBI chrNW_004936546:3,737,908...3,783,492
Ensembl chrNW_004936546:3,737,851...3,783,588
|
|
G |
Aifm1 |
apoptosis inducing factor mitochondria associated 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25743375 |
|
NCBI chrNW_004936479:1,441,508...1,477,133
Ensembl chrNW_004936479:1,441,437...1,478,107
|
|
G |
Ak4 |
adenylate kinase 4 |
|
ISO |
protein:increased expression:liver (rat) |
RGD |
PMID:16538043 |
RGD:2301096 |
NCBI chrNW_004936692:2,593,409...2,654,583
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:29763686 PMID:32805337 |
RGD:27226688 |
NCBI chrNW_004936474:26,680,736...26,696,996
Ensembl chrNW_004936474:26,680,676...26,697,214
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family member L2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936492:9,605,611...9,657,717
Ensembl chrNW_004936492:9,605,708...9,657,743
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
severity susceptibility |
ISO |
DNA:deletion:exon 3 (mouse) protein:increased expression:liver |
RGD |
PMID:21138988 PMID:24492981 PMID:30121625 |
RGD:14975148 RGD:15036810 RGD:7241599 |
NCBI chrNW_004936558:4,362,693...4,387,705
Ensembl chrNW_004936558:4,362,654...4,390,414
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936481:19,630,045...19,650,009
|
|
G |
Aldob |
aldolase, fructose-bisphosphate B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16115720 |
|
NCBI chrNW_004936524:9,584,302...9,592,961
Ensembl chrNW_004936524:9,584,140...9,596,276
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18779383 |
|
NCBI chrNW_004936487:3,399,792...3,412,088
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936471:21,274,112...21,329,286
Ensembl chrNW_004936471:21,274,027...21,329,503
|
|
G |
Anxa6 |
annexin A6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936647:3,978,047...4,029,485
Ensembl chrNW_004936647:3,976,903...4,029,485
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936542:2,111,055...2,112,626
Ensembl chrNW_004936542:2,111,052...2,112,854
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G |
Apoh |
apolipoprotein H |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:plasma: |
CTD RGD |
PMID:16099942 PMID:23288050 |
RGD:10054107 |
NCBI chrNW_004936541:6,683,483...6,695,094
Ensembl chrNW_004936541:6,683,534...6,695,066
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20935161 |
|
NCBI chrNW_004936580:1,038,420...1,093,319
Ensembl chrNW_004936580:1,036,973...1,082,984
|
|
G |
Atg5 |
autophagy related 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22491424 |
|
NCBI chrNW_004936564:2,759,085...2,885,394
Ensembl chrNW_004936564:2,758,598...2,885,420
|
|
G |
Atoh8 |
atonal bHLH transcription factor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936712:1,529,508...1,552,148
Ensembl chrNW_004936712:1,529,420...1,552,185
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
|
|
G |
Bad |
BCL2 associated agonist of cell death |
treatment |
ISO |
|
RGD |
PMID:25447754 |
RGD:10053709 |
NCBI chrNW_004936599:4,924,349...4,933,683
Ensembl chrNW_004936599:4,924,789...4,933,368
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17906064 |
|
NCBI chrNW_004936664:2,968,103...2,973,652
Ensembl chrNW_004936664:2,967,865...2,973,820
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936833:367,790...409,966
Ensembl chrNW_004936833:367,710...410,139
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30685357 |
|
NCBI chrNW_004936604:548,844...551,031
Ensembl chrNW_004936604:548,847...549,956
|
|
G |
Blvrb |
biliverdin reductase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936661:2,808,998...2,818,123
Ensembl chrNW_004936661:2,808,950...2,818,178
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:36602574 |
|
NCBI chrNW_004936528:5,167,611...5,239,128
Ensembl chrNW_004936528:5,164,481...5,239,128
|
|
G |
Bpnt1 |
3'(2'), 5'-bisphosphate nucleotidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936650:2,113,933...2,138,487
Ensembl chrNW_004936650:2,113,649...2,138,934
|
|
G |
Brd4 |
bromodomain containing 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936596:5,176,682...5,246,102
Ensembl chrNW_004936596:5,177,147...5,246,518
|
|
G |
C3 |
complement C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
Ca3 |
carbonic anhydrase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 PMID:25231249 |
|
NCBI chrNW_004936544:337,437...347,760
Ensembl chrNW_004936544:337,382...348,462
|
|
G |
Cabp1 |
calcium binding protein 1 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:21138988 |
RGD:7241599 |
NCBI chrNW_004936668:324,299...339,334
|
|
G |
Cadps2 |
calcium dependent secretion activator 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936605:2,505,064...3,012,322
Ensembl chrNW_004936605:2,505,231...3,011,468
|
|
G |
Canx |
calnexin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936739:1,051,853...1,085,658
Ensembl chrNW_004936739:1,051,240...1,086,405
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936474:21,854,454...21,881,622
Ensembl chrNW_004936474:21,854,330...21,881,622
|
|
G |
Casp8 |
caspase 8 |
treatment |
ISO |
|
RGD |
PMID:25447754 |
RGD:10053709 |
NCBI chrNW_004936726:554,627...596,334
Ensembl chrNW_004936726:554,758...595,922
|
|
G |
Cast |
calpastatin |
|
ISO |
|
RGD |
PMID:16871587 |
RGD:5683869 |
NCBI chrNW_004936523:6,688,153...6,798,184
Ensembl chrNW_004936523:6,686,519...6,798,321
|
|
G |
Cat |
catalase |
|
ISO |
protein:decreased expression:liver CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20623750 PMID:21138988 PMID:25231249 |
RGD:7241599 |
NCBI chrNW_004936533:3,601,270...3,637,128
Ensembl chrNW_004936533:3,600,955...3,637,422
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936536:294,650...330,875
Ensembl chrNW_004936536:293,549...330,998
|
|
G |
Cct3 |
chaperonin containing TCP1 subunit 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936580:5,537,338...5,554,384
Ensembl chrNW_004936580:5,537,015...5,554,384
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936643:2,354,799...2,368,048
Ensembl chrNW_004936643:2,354,799...2,368,048
|
|
G |
Cdc25b |
cell division cycle 25B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936485:14,897,050...14,914,034
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936738:160,346...227,687
Ensembl chrNW_004936738:160,338...227,775
|
|
G |
Cela1 |
chymotrypsin like elastase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936512:8,901,674...8,919,819
Ensembl chrNW_004936512:8,905,339...8,919,819
|
|
G |
Cfap20 |
cilia and flagella associated protein 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936475:10,011,671...10,023,643
Ensembl chrNW_004936475:10,011,616...10,023,756
|
|
G |
Chrm3 |
cholinergic receptor muscarinic 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20197374 |
|
NCBI chrNW_004936484:13,953,141...14,373,174
Ensembl chrNW_004936484:13,954,887...13,956,659
|
|
G |
Ckb |
creatine kinase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936621:1,612,398...1,615,821
Ensembl chrNW_004936621:1,612,393...1,615,822
|
|
G |
Clu |
clusterin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chrNW_004936675:499,745...513,515
Ensembl chrNW_004936675:499,199...513,836
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936470:26,440,606...26,643,015
Ensembl chrNW_004936470:26,440,615...26,643,015
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16679477 |
|
NCBI chrNW_004936506:8,886,494...8,923,921
Ensembl chrNW_004936506:8,886,494...8,923,930
|
|
G |
Comt |
catechol-O-methyltransferase |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:21138988 |
RGD:7241599 |
NCBI chrNW_004936619:3,847,059...3,883,866
Ensembl chrNW_004936619:3,876,299...3,882,747
|
|
G |
Coq9 |
coenzyme Q9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936475:9,502,638...9,517,601
Ensembl chrNW_004936475:9,502,681...9,516,936
|
|
G |
Cp |
ceruloplasmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936519:6,431,156...6,473,183
Ensembl chrNW_004936519:6,431,144...6,481,858
|
|
G |
Cpb2 |
carboxypeptidase B2 |
|
ISO |
mRNA,protein:increased expression,increased activity:liver,plasma |
RGD |
PMID:19386599 |
RGD:7243112 |
NCBI chrNW_004936857:577,067...609,855
Ensembl chrNW_004936857:577,585...626,267
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936586:5,739,038...5,850,317
Ensembl chrNW_004936586:5,739,337...5,850,312
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
|
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:28959666 |
RGD:401794432 |
NCBI chrNW_004936599:1,491,934...1,535,101
Ensembl chrNW_004936599:1,482,172...1,535,119
|
|
G |
Crp |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936740:885,855...888,854
Ensembl chrNW_004936740:883,272...890,606
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20005281 PMID:33882750 |
|
NCBI chrNW_004936490:15,142,526...15,146,375
Ensembl chrNW_004936490:15,142,808...15,144,487
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19679878 |
|
NCBI chrNW_004936473:29,999,542...30,034,610
Ensembl chrNW_004936473:29,999,562...30,038,293
|
|
G |
Ctse |
cathepsin E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936557:6,485,783...6,498,805
Ensembl chrNW_004936557:6,485,755...6,498,833
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11739529 |
|
NCBI chrNW_004936676:60,869...63,028
Ensembl chrNW_004936676:60,621...63,106
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:38614205 |
|
NCBI chrNW_004936597:2,746,415...2,754,169
Ensembl chrNW_004936597:2,746,296...2,754,716
|
|
G |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936748:342,655...386,017
Ensembl chrNW_004936748:342,394...386,000
|
|
G |
Ddb1 |
damage specific DNA binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936581:1,710,382...1,742,598
Ensembl chrNW_004936581:1,710,382...1,742,598
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chrNW_004936498:4,514,212...4,544,523
Ensembl chrNW_004936498:4,514,184...4,544,527
|
|
G |
Dhfr |
dihydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19648163 |
|
NCBI chrNW_004936469:67,962...83,116
|
|
G |
Dlat |
dihydrolipoamide S-acetyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936612:2,395,452...2,437,592
Ensembl chrNW_004936612:2,393,071...2,437,522
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936653:1,554,534...1,558,832
Ensembl chrNW_004936653:1,554,553...1,559,170
|
|
G |
Dnajc12 |
DnaJ heat shock protein family (Hsp40) member C12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936521:10,360,775...10,403,201
Ensembl chrNW_004936521:10,360,952...10,402,877
|
|
G |
Dsc2 |
desmocollin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936682:2,057,331...2,091,034
Ensembl chrNW_004936682:2,057,190...2,164,429
|
|
G |
E2f1 |
E2F transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30515189 |
|
NCBI chrNW_004936561:6,894,827...6,901,058
Ensembl chrNW_004936561:6,896,063...6,900,026
|
|
G |
Echdc1 |
ethylmalonyl-CoA decarboxylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936639:2,351,777...2,394,539
Ensembl chrNW_004936639:2,351,372...2,397,027
|
|
G |
Echs1 |
enoyl-CoA hydratase, short chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936486:19,488,619...19,496,583
Ensembl chrNW_004936486:19,488,554...19,496,575
|
|
G |
Edem1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936577:4,486,617...4,516,379
Ensembl chrNW_004936577:4,486,885...4,513,555
|
|
G |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25411909 |
|
NCBI chrNW_004936750:389,913...430,783
Ensembl chrNW_004936750:389,845...432,460
|
|
G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936521:8,182,740...8,207,466
Ensembl chrNW_004936521:8,184,539...8,207,472
|
|
G |
Endog |
endonuclease G |
|
ISO |
protein:decreased expression:mitochondrion: |
RGD |
PMID:22509279 |
RGD:9685364 |
NCBI chrNW_004936487:16,282,115...16,285,486
Ensembl chrNW_004936487:16,282,398...16,285,418
|
|
G |
Eng |
endoglin |
|
ISO |
protein:increased expression:liver (rat) |
RGD |
PMID:21146604 |
RGD:7257529 |
NCBI chrNW_004936487:15,467,165...15,499,180
Ensembl chrNW_004936487:15,467,835...15,477,488
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 PMID:25231249 |
|
NCBI chrNW_004936623:3,115,357...3,130,289
Ensembl chrNW_004936623:3,115,081...3,128,183
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
ISO |
protein:increased activity:serum: |
RGD |
PMID:17850827 |
RGD:9685426 |
NCBI chrNW_004936470:26,994,549...27,099,758
Ensembl chrNW_004936470:26,994,215...27,100,999
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936526:2,589,254...2,652,831
Ensembl chrNW_004936526:2,614,059...2,653,286
|
|
G |
Erlec1 |
endoplasmic reticulum lectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936491:351,813...377,978
Ensembl chrNW_004936491:351,420...378,441
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30538632 |
|
NCBI chrNW_004936541:4,613,197...4,705,911
Ensembl chrNW_004936541:4,617,555...4,705,866
|
|
G |
F13a1 |
coagulation factor XIII A chain |
|
ISO |
|
RGD |
PMID:22019897 |
RGD:11041813 |
NCBI chrNW_004936534:6,199,066...6,360,374
Ensembl chrNW_004936534:6,199,066...6,361,476
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22407844 |
|
NCBI chrNW_004936537:4,637,028...4,647,915
Ensembl chrNW_004936537:4,636,667...4,647,916
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
ISO |
|
RGD |
PMID:25447754 PMID:26062544 |
RGD:10053709 RGD:11341803 |
NCBI chrNW_004936599:633,501...639,412
Ensembl chrNW_004936599:633,330...639,456
|
|
G |
Fads1 |
fatty acid desaturase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936581:1,312,199...1,327,046
Ensembl chrNW_004936581:1,312,183...1,327,998
|
|
G |
Fads2 |
fatty acid desaturase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936581:1,203,410...1,233,330
Ensembl chrNW_004936581:1,203,366...1,233,469
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
protein:increased expression:liver (rat) |
RGD |
PMID:16831245 |
RGD:8662853 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Fasn |
fatty acid synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936594:5,591,785...5,609,886
Ensembl chrNW_004936594:5,592,609...5,608,972
|
|
G |
Fcmr |
Fc mu receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936557:5,707,138...5,718,192
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20974703 |
|
NCBI chrNW_004936576:1,322,406...1,329,743
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
severity |
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:29883717 |
RGD:15045603 |
NCBI chrNW_004936664:2,826,823...2,828,330
Ensembl chrNW_004936664:2,826,823...2,828,330
|
|
G |
Flt1 |
fms related receptor tyrosine kinase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21135413 |
|
NCBI chrNW_004936472:23,442,946...23,617,523
Ensembl chrNW_004936472:23,440,088...23,617,041
|
|
G |
Ftl |
ferritin light chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936664:2,976,325...2,977,878
Ensembl chrNW_004936664:2,976,314...2,977,877
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
|
ISO |
mRNA:decreased expression:liver (mouse) |
RGD |
PMID:28189721 |
RGD:14695531 |
NCBI chrNW_004936490:17,605,865...17,614,754
Ensembl chrNW_004936490:17,605,865...17,615,145
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
treatment |
ISO |
|
RGD |
PMID:21864513 |
RGD:10449168 |
NCBI chrNW_004936809:1,269,900...1,285,853
Ensembl chrNW_004936809:1,269,914...1,285,889
|
|
G |
Gadd45a |
growth arrest and DNA damage inducible alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chrNW_004936591:3,998,359...4,001,491
Ensembl chrNW_004936591:3,998,340...4,001,830
|
|
G |
Ganab |
glucosidase II alpha subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936581:613,292...633,075
Ensembl chrNW_004936581:613,253...634,130
|
|
G |
Gc |
GC vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936598:3,220,029...3,256,091
Ensembl chrNW_004936598:3,219,991...3,261,629
|
|
G |
Gclc |
glutamate-cysteine ligase catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17573345 PMID:19481141 |
RGD:10402383 |
NCBI chrNW_004936476:7,371,270...7,418,756
Ensembl chrNW_004936476:7,371,149...7,418,958
|
|
G |
Gda |
guanine deaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936503:8,191,925...8,279,806
Ensembl chrNW_004936503:8,192,049...8,278,790
|
|
G |
Gdi1 |
GDP dissociation inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936809:1,188,793...1,194,816
Ensembl chrNW_004936809:1,188,628...1,194,863
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
|
RGD |
PMID:15968720 PMID:22033404 |
RGD:9685722 RGD:9685727 |
NCBI chrNW_004936694:2,051,362...2,053,812
Ensembl chrNW_004936694:2,051,325...2,053,818
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21219404 |
|
NCBI chrNW_004936496:10,485,528...10,505,506
Ensembl chrNW_004936496:10,485,504...10,505,842
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
ISO |
|
RGD |
PMID:10934156 |
RGD:14701049 |
NCBI chrNW_004936619:762,278...791,610
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:34151639 |
|
NCBI chrNW_004936602:3,037,862...3,044,863
Ensembl chrNW_004936602:3,038,549...3,042,506
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33483742 |
|
NCBI chrNW_004936601:5,415,857...5,435,964
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936636:617,376...640,424
Ensembl chrNW_004936636:617,356...640,932
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936512:7,762,325...7,770,007
Ensembl chrNW_004936512:7,762,643...7,770,309
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression, activity:serum: |
CTD RGD |
PMID:145039 PMID:19085960 PMID:19481104 PMID:21772750 PMID:27293452 PMID:28487901 More...
|
RGD:14975162 RGD:14975166 RGD:14975168 RGD:14975249 |
NCBI chrNW_004936470:7,765,810...7,770,837
Ensembl chrNW_004936470:7,765,703...7,768,465
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
|
ISO |
protein:increased expression, activity:serum: |
RGD |
PMID:19085960 |
RGD:14975249 |
NCBI chrNW_004936475:262,558...299,766
Ensembl chrNW_004936475:262,920...297,459
|
|
G |
Gsn |
gelsolin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936487:9,749,755...9,802,787
Ensembl chrNW_004936487:9,764,944...9,802,841
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver |
RGD CTD |
PMID:23554813 PMID:24154663 PMID:25226513 PMID:28069987 |
RGD:10401878 RGD:7257532 |
NCBI chrNW_004936792:531,076...579,083
Ensembl chrNW_004936792:531,756...579,166
|
|
G |
Gstm3 |
glutathione S-transferase mu 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25743375 |
|
NCBI chrNW_004936704:1,233,909...1,236,864
Ensembl chrNW_004936704:1,233,780...1,237,329
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936600:1,932,152...1,943,342
Ensembl chrNW_004936600:1,930,695...1,943,422
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 PMID:25226513 |
|
NCBI chrNW_004936599:2,197,681...2,200,642
Ensembl chrNW_004936599:2,197,634...2,201,050
|
|
G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936473:2,823,183...2,856,077
Ensembl chrNW_004936473:2,823,123...2,856,077
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936493:6,182,786...6,224,601
Ensembl chrNW_004936493:6,182,261...6,224,693
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
|
ISO |
mRNA:increased expression:hepatocyte |
RGD |
PMID:24373749 |
RGD:11041724 |
NCBI chrNW_004936570:1,009,344...1,010,654
Ensembl chrNW_004936570:1,009,312...1,010,686
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936627:4,167,501...4,179,596
Ensembl chrNW_004936627:4,159,214...4,179,806
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chrNW_004936515:6,030,402...6,051,161
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19783637 PMID:29091898 |
RGD:15090820 |
NCBI chrNW_004936472:25,236,728...25,246,585
Ensembl chrNW_004936472:25,236,728...25,246,580
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
RGD CTD |
PMID:18227147 PMID:22688006 PMID:22886620 PMID:29091898 |
RGD:10762620 RGD:15090820 |
NCBI chrNW_004936492:5,042,353...5,049,216
Ensembl chrNW_004936492:5,042,330...5,049,311
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936691:650,753...694,362
Ensembl chrNW_004936691:652,769...694,463
|
|
G |
Hpx |
hemopexin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936842:485,515...495,684
Ensembl chrNW_004936842:485,517...494,742
|
|
G |
Hrh2 |
histamine receptor H2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22926047 |
|
NCBI chrNW_004936609:624,446...664,049
Ensembl chrNW_004936609:622,311...664,084
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936487:13,348,465...13,352,717
Ensembl chrNW_004936487:13,348,465...13,352,717
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
protein:altered localization:liver (rat) |
RGD |
PMID:12376827 |
RGD:10059389 |
NCBI chrNW_004936542:7,577,192...7,581,598
Ensembl chrNW_004936542:7,577,149...7,581,923
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
|
RGD |
PMID:29091898 |
RGD:15090820 |
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
severity |
ISO |
|
RGD |
PMID:31121248 |
RGD:14985250 |
NCBI chrNW_004936483:15,845,777...15,864,341
Ensembl chrNW_004936483:15,845,792...15,864,341
|
|
G |
Ido2 |
indoleamine 2,3-dioxygenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32289347 |
|
NCBI chrNW_004936843:595,237...649,390
Ensembl chrNW_004936843:594,968...649,390
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:12153990 PMID:21245496 PMID:30013034 |
RGD:14975100 |
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23639586 PMID:25226513 |
|
NCBI chrNW_004936492:11,709,623...11,784,028
Ensembl chrNW_004936492:11,709,222...11,778,351
|
|
G |
Il11 |
interleukin 11 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11421492 |
|
NCBI chrNW_004936886:617,531...620,661
Ensembl chrNW_004936886:618,419...621,772
|
|
G |
Il12b |
interleukin 12B |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:36520315 |
|
NCBI chrNW_004936515:4,056,214...4,066,121
Ensembl chrNW_004936515:4,056,214...4,065,076
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19633216 PMID:24949944 |
|
NCBI chrNW_004936476:8,621,860...8,625,008
Ensembl chrNW_004936476:8,621,860...8,625,008
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19164858 |
|
NCBI chrNW_004936612:2,306,963...2,325,086
Ensembl chrNW_004936612:2,306,875...2,325,189
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8218930 |
|
NCBI chrNW_004936783:1,210,715...1,218,315
Ensembl chrNW_004936783:1,210,809...1,218,315
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
RGD CTD |
PMID:19164858 PMID:23102243 PMID:28138970 PMID:29091898 PMID:29278859 PMID:31077717 PMID:31342809 More...
|
RGD:13793380 RGD:14975281 RGD:15036799 RGD:15090820 RGD:7204421 |
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chrNW_004936713:679,680...716,801
Ensembl chrNW_004936713:701,155...716,650
|
|
G |
Il22 |
interleukin 22 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15122762 PMID:16212920 PMID:23375450 |
|
NCBI chrNW_004936545:6,227,118...6,231,745
Ensembl chrNW_004936545:6,227,118...6,231,745
|
|
G |
Il6 |
interleukin 6 |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:7532385 PMID:15763341 PMID:29091898 |
RGD:15090820 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Immt |
inner membrane mitochondrial protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936712:1,257,427...1,301,045
Ensembl chrNW_004936712:1,257,575...1,300,729
|
|
G |
Irak1 |
interleukin 1 receptor associated kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936809:891,407...900,311
Ensembl chrNW_004936809:890,717...900,326
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936577:3,896,455...4,198,396
Ensembl chrNW_004936577:3,896,390...4,198,411
|
|
G |
Keap1 |
kelch like ECH associated protein 1 |
|
ISO |
|
RGD |
PMID:18417483 |
RGD:6893370 |
NCBI chrNW_004936659:785,059...793,775
Ensembl chrNW_004936659:782,340...793,688
|
|
G |
Kitlg |
KIT ligand |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12594235 |
|
NCBI chrNW_004936507:5,566,144...5,650,412
Ensembl chrNW_004936507:5,565,821...5,650,828
|
|
G |
Kng1 |
kininogen 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20362651 PMID:30685357 |
|
NCBI chrNW_004936578:3,255,335...3,281,296
Ensembl chrNW_004936578:3,253,749...3,281,296
|
|
G |
Krt18 |
keratin 18 |
|
ISO |
mRNA, protein:increased expression:liver (mouse) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:17340120 PMID:19783637 PMID:33483742 PMID:38521541 |
RGD:18337498 |
NCBI chrNW_004936512:10,290,706...10,294,647
Ensembl chrNW_004936512:10,290,690...10,294,651
|
|
G |
Krt8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936512:10,247,049...10,254,748
Ensembl chrNW_004936512:10,246,991...10,254,827
|
|
G |
Lap3 |
leucine aminopeptidase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936477:10,596,610...10,627,149
Ensembl chrNW_004936477:10,596,416...10,627,239
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936561:3,017,471...3,035,481
Ensembl chrNW_004936561:3,016,926...3,035,552
|
|
G |
Lcat |
lecithin-cholesterol acyltransferase |
|
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:28959666 |
RGD:401794432 |
NCBI chrNW_004936475:18,294,013...18,297,433
Ensembl chrNW_004936475:18,293,716...18,298,248
|
|
G |
Lcn2 |
lipocalin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20362651 PMID:20623750 |
|
NCBI chrNW_004936487:15,721,752...15,725,396
Ensembl chrNW_004936487:15,721,684...15,728,221
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36108984 |
|
NCBI chrNW_004936659:1,259,405...1,300,545
Ensembl chrNW_004936659:1,259,369...1,302,294
|
|
G |
Lgals3 |
galectin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22461450 |
|
NCBI chrNW_004936697:20,861...38,568
Ensembl chrNW_004936697:27,145...38,586
|
|
G |
Lipc |
lipase C, hepatic type |
|
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:28959666 |
RGD:401794432 |
NCBI chrNW_004936471:19,604,083...19,733,721
Ensembl chrNW_004936471:19,703,236...19,733,686
|
|
G |
LOC101958062 |
glutathione S-transferase A4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936476:7,873,218...7,888,301
Ensembl chrNW_004936476:7,873,194...7,889,048
|
|
G |
LOC101958900 |
glutathione S-transferase Mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936704:1,142,990...1,150,491
Ensembl chrNW_004936704:1,143,010...1,148,567
|
|
G |
LOC101959495 |
PZP alpha-2-macroglobulin like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936870:497,071...542,364
|
|
G |
LOC101960095 |
antileukoproteinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chrNW_004936514:7,618,382...7,620,790
Ensembl chrNW_004936514:7,618,261...7,620,912
|
|
G |
LOC101961588 |
cytochrome P450 2D17 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:27490558 |
RGD:14700879 |
NCBI chrNW_004936718:153,340...157,966
|
|
G |
LOC101961662 |
biotinidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15469856 |
|
NCBI chrNW_004936473:2,787,386...2,823,014
|
|
G |
LOC101966596 |
dehydrogenase/reductase SDR family member 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936495:4,341,261...4,358,279
Ensembl chrNW_004936495:4,339,700...4,358,547
|
|
G |
LOC101966907 |
histone H2AX |
treatment |
ISO |
|
RGD |
PMID:23265463 |
RGD:8693741 |
NCBI chrNW_004936542:4,046,930...4,049,017
Ensembl chrNW_004936542:4,047,915...4,048,346
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:25143335 |
RGD:25671447 |
NCBI chrNW_004936541:4,157,847...4,178,156
Ensembl chrNW_004936541:4,157,393...4,178,177
|
|
G |
LOC101969148 |
cytochrome P450 1A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33814510 |
|
NCBI chrNW_004936471:33,682,730...33,688,332
Ensembl chrNW_004936471:33,682,730...33,688,332
|
|
G |
LOC101969421 |
cytochrome P450 1A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28762043 |
|
NCBI chrNW_004936471:33,704,616...33,709,455
Ensembl chrNW_004936471:33,703,792...33,709,484
|
|
G |
LOC101970101 |
cytochrome P450 1B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33814510 |
|
NCBI chrNW_004936663:345,021...355,188
Ensembl chrNW_004936663:348,368...355,191
|
|
G |
LOC101970597 |
sulfotransferase 1C1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936729:1,783,124...1,796,723
Ensembl chrNW_004936729:1,783,105...1,796,740
|
|
G |
LOC101970831 |
serotransferrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936529:6,917,762...6,947,512
Ensembl chrNW_004936529:6,855,958...6,947,394
|
|
G |
LOC101972766 |
tubulin alpha-1A chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936512:6,959,656...6,964,299
Ensembl chrNW_004936512:6,958,985...6,964,299
|
|
G |
LOC101973017 |
corticosteroid-binding globulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936733:2,141,484...2,148,129
Ensembl chrNW_004936733:2,141,392...2,148,151
|
|
G |
LOC101973029 |
cytochrome P450 2E1 |
treatment |
ISO |
DNA:hypermethylation:promoter associated with Endotoxemia CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:12668988 PMID:16770646 PMID:21741958 PMID:25681370 PMID:27324775 PMID:27490558 PMID:27960551 PMID:28762043 PMID:29404441 More...
|
RGD:14700872 RGD:14700873 RGD:14700878 RGD:14700879 RGD:14700901 |
NCBI chrNW_004936486:19,691,822...19,702,684
Ensembl chrNW_004936486:19,691,822...19,702,102
|
|
G |
LOC101977223 |
7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25448281 |
|
NCBI chrNW_004936695:2,263,868...2,265,373
Ensembl chrNW_004936695:2,263,868...2,265,373
|
|
G |
LOC101977655 |
glutamate--cysteine ligase regulatory subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936537:5,356,914...5,378,998
|
|
G |
LOC101978323 |
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial |
|
ISO |
mRNA, protein:decreased expression:kidney (mouse) |
RGD |
PMID:26476181 |
RGD:25671412 |
NCBI chrNW_004936646:1,899,686...1,904,104
Ensembl chrNW_004936646:1,900,259...1,904,104
|
|
G |
Lpl |
lipoprotein lipase |
treatment |
ISO |
|
RGD |
PMID:27071702 |
RGD:13794380 |
NCBI chrNW_004936555:4,084,099...4,108,219
Ensembl chrNW_004936555:4,084,099...4,108,365
|
|
G |
Lrat |
lecithin retinol acyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936576:1,491,480...1,498,568
Ensembl chrNW_004936576:1,492,297...1,501,917
|
|
G |
Ltb4r |
leukotriene B4 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28487374 |
|
NCBI chrNW_004936722:232,320...233,802
|
|
G |
Ltf |
lactotransferrin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16141546 |
|
NCBI chrNW_004936596:344,287...373,788
Ensembl chrNW_004936596:344,274...373,952
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18700144 |
|
NCBI chrNW_004936560:3,988,696...4,197,953
Ensembl chrNW_004936560:3,989,420...4,197,501
|
|
G |
Mat1a |
methionine adenosyltransferase 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936716:126,628...142,986
Ensembl chrNW_004936716:126,574...143,155
|
|
G |
Mccc1 |
methylcrotonyl-CoA carboxylase subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936566:409,558...468,898
Ensembl chrNW_004936566:409,462...469,225
|
|
G |
Mdh1 |
malate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936491:8,570,472...8,586,914
Ensembl chrNW_004936491:8,570,472...8,587,686
|
|
G |
Me1 |
malic enzyme 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936510:7,425,983...7,571,090
Ensembl chrNW_004936510:7,426,347...7,571,553
|
|
G |
Med1 |
mediator complex subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16109766 |
|
NCBI chrNW_004936490:14,625,201...14,663,184
Ensembl chrNW_004936490:14,625,897...14,657,802
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15763341 |
|
NCBI chrNW_004936475:7,801,356...7,825,831
Ensembl chrNW_004936475:7,801,277...7,825,851
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22507835 |
|
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
|
|
G |
Mst1 |
macrophage stimulating 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936529:1,298,853...1,306,088
Ensembl chrNW_004936529:1,299,300...1,303,959
|
|
G |
Mst1r |
macrophage stimulating 1 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22575169 |
|
NCBI chrNW_004936529:1,494,748...1,509,925
Ensembl chrNW_004936529:1,495,059...1,509,901
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
treatment |
ISO |
associated with precursor lymphoblastic lymphoma/leukemia; DNA:SNP: :677C>T(human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:18551038 PMID:19648163 PMID:30545275 |
RGD:14696733 |
NCBI chrNW_004936474:623,438...637,849
Ensembl chrNW_004936474:623,291...638,193
|
|
G |
Mtpn |
myotrophin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936592:644,618...679,615
Ensembl chrNW_004936592:644,430...679,800
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
ameliorates |
ISO |
|
RGD |
PMID:17615358 |
RGD:150521532 |
NCBI chrNW_004936473:27,672,237...27,676,339
Ensembl chrNW_004936473:27,671,797...27,676,372
|
|
G |
Ndufs3 |
NADH:ubiquinone oxidoreductase core subunit S3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936562:1,667,780...1,674,670
Ensembl chrNW_004936562:1,664,293...1,674,670
|
|
G |
Nfatc4 |
nuclear factor of activated T cells 4 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:34192554 |
|
NCBI chrNW_004936722:178,866...187,847
Ensembl chrNW_004936722:179,200...187,800
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
treatment |
ISO |
CTD Direct Evidence: therapeutic induced by methotrexate (CHEBI:44185), treated by ferulic acid (CHEBI:17620) |
RGD CTD |
PMID:18417483 PMID:22491424 PMID:22627062 PMID:24813929 PMID:26958860 PMID:29091898 PMID:30215777 PMID:31889292 PMID:31927046 PMID:31972209 PMID:32066295 More...
|
RGD:15090820 RGD:21201280 RGD:21201283 RGD:21201305 RGD:21201308 RGD:6893370 |
NCBI chrNW_004936509:6,589,967...6,621,171
Ensembl chrNW_004936509:6,590,630...6,620,262
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
susceptibility treatment |
ISO |
associated with tuberculosis ;DNA:SNPs,haplotypes: 3'utr,5'utr: (rs78872571,rs4647992) (human) |
RGD |
PMID:29091898 PMID:31490979 |
RGD:15090820 RGD:40902984 |
NCBI chrNW_004936520:733,760...850,563
Ensembl chrNW_004936520:733,668...829,435
|
|
G |
Nfxl1 |
nuclear transcription factor, X-box binding like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936482:14,008,825...14,062,654
Ensembl chrNW_004936482:14,009,724...14,062,207
|
|
G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936490:10,634,788...10,640,182
Ensembl chrNW_004936490:10,633,454...10,649,914
|
|
G |
Notch1 |
notch receptor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30394310 |
|
NCBI chrNW_004936669:1,292,016...1,334,061
Ensembl chrNW_004936669:1,292,088...1,332,428
|
|
G |
Nox4 |
NADPH oxidase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936736:230,465...394,859
Ensembl chrNW_004936736:230,476...396,708
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
|
RGD |
PMID:28472605 PMID:28522909 PMID:29091898 |
RGD:13439737 RGD:13439739 RGD:15090820 |
NCBI chrNW_004936475:19,771,384...19,785,034
Ensembl chrNW_004936475:19,769,488...19,785,311
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0 group B member 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29943110 |
|
NCBI chrNW_004936474:11,316,857...11,319,669
Ensembl chrNW_004936474:11,316,700...11,319,669
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1 group D member 1 |
treatment |
ISO |
|
RGD |
PMID:24497272 |
RGD:10448995 |
NCBI chrNW_004936490:15,206,194...15,213,858
Ensembl chrNW_004936490:15,206,191...15,213,867
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1 group H member 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17256725 |
|
NCBI chrNW_004936562:1,937,665...1,946,680
Ensembl chrNW_004936562:1,937,667...1,946,669
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1 group H member 4 |
severity treatment |
ISO |
mRNA:decreased expression:liver (rat) CTD Direct Evidence: marker/mechanism protein:decreased expression:liver (rat) |
RGD CTD |
PMID:12875239 PMID:20573685 PMID:22711662 PMID:28827769 PMID:29091898 PMID:30068870 More...
|
RGD:14701035 RGD:14701036 RGD:15042870 RGD:15045609 RGD:15090820 |
NCBI chrNW_004936492:13,315,265...13,365,186
Ensembl chrNW_004936492:13,315,265...13,374,034
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1 group I member 2 |
susceptibility |
ISO |
associated with tuberculosis ;DNA:SNP,haplotypes:promoter: (rs3814055) (human) CTD Direct Evidence: marker/mechanism|therapeutic |
RGD CTD |
PMID:19797606 PMID:28058446 PMID:31490979 |
RGD:40902984 |
NCBI chrNW_004936536:6,691,590...6,726,421
Ensembl chrNW_004936536:6,691,590...6,726,704
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1 group I member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:14742670 PMID:25656644 PMID:28058446 |
|
NCBI chrNW_004936903:527,838...533,930
Ensembl chrNW_004936903:527,871...533,790
|
|
G |
Nr2f2 |
nuclear receptor subfamily 2 group F member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936483:6,886,447...6,900,986
Ensembl chrNW_004936483:6,886,153...6,900,997
|
|
G |
Nr5a2 |
nuclear receptor subfamily 5 group A member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29515023 |
|
NCBI chrNW_004936567:4,084,161...4,194,858
Ensembl chrNW_004936567:4,084,608...4,212,854
|
|
G |
Nrep |
neuronal regeneration related protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936531:6,077,691...6,105,517
Ensembl chrNW_004936531:6,077,716...6,104,479
|
|
G |
Ntn1 |
netrin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:35292334 |
|
NCBI chrNW_004936595:2,146,371...2,323,346
Ensembl chrNW_004936595:2,146,366...2,323,399
|
|
G |
Nus1 |
NUS1 dehydrodolichyl diphosphate synthase subunit |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:33812996 |
|
NCBI chrNW_004936658:695,431...718,891
Ensembl chrNW_004936658:695,609...718,746
|
|
G |
Ociad1 |
OCIA domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936482:14,780,284...14,805,718
Ensembl chrNW_004936482:14,780,326...14,807,182
|
|
G |
Ogdh |
oxoglutarate dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936478:19,506,845...19,584,411
Ensembl chrNW_004936478:19,506,154...19,583,364
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936594:5,368,199...5,379,215
Ensembl chrNW_004936594:5,367,816...5,379,252
|
|
G |
Pah |
phenylalanine hydroxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936492:11,342,566...11,412,323
Ensembl chrNW_004936492:11,342,518...11,412,209
|
|
G |
Pan2 |
poly(A) specific ribonuclease subunit PAN2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936646:719,821...737,284
Ensembl chrNW_004936646:720,393...736,467
|
|
G |
Panx1 |
pannexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29246445 |
|
NCBI chrNW_004936674:736,911...773,406
Ensembl chrNW_004936674:736,905...773,412
|
|
G |
Park7 |
Parkinsonism associated deglycase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936623:2,422,780...2,436,817
Ensembl chrNW_004936623:2,422,833...2,436,817
|
|
G |
Pc |
pyruvate carboxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936599:2,677,770...2,793,033
Ensembl chrNW_004936599:2,677,583...2,793,197
|
|
G |
Pcolce |
procollagen C-endopeptidase enhancer |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936543:653,844...659,905
Ensembl chrNW_004936543:653,824...659,883
|
|
G |
Pcyt1a |
phosphate cytidylyltransferase 1A, choline |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936784:884,751...938,901
Ensembl chrNW_004936784:884,751...938,282
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:21182459 PMID:31809757 |
|
NCBI chrNW_004936585:4,701,012...4,713,421
Ensembl chrNW_004936585:4,700,418...4,714,450
|
|
G |
Pdlim5 |
PDZ and LIM domain 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936687:1,944,095...2,152,501
Ensembl chrNW_004936687:1,944,095...2,152,529
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936483:15,474,484...15,480,527
Ensembl chrNW_004936483:15,472,949...15,480,648
|
|
G |
Pgm1 |
phosphoglucomutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936692:1,160,836...1,221,270
Ensembl chrNW_004936692:1,160,623...1,221,746
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22507835 |
|
NCBI chrNW_004936785:476,200...503,371
Ensembl chrNW_004936785:476,078...503,321
|
|
G |
Plg |
plasminogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22507835 |
|
NCBI chrNW_004936489:11,775,243...11,808,482
Ensembl chrNW_004936489:11,775,243...11,805,651
|
|
G |
Pls3 |
plastin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936499:246,042...335,440
Ensembl chrNW_004936499:246,042...335,440
|
|
G |
Pnp |
purine nucleoside phosphorylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936877:686,539...692,832
|
|
G |
Pnrc1 |
proline rich nuclear receptor coactivator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936510:3,109,114...3,112,616
Ensembl chrNW_004936510:3,107,147...3,112,813
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
no_association susceptibility |
ISO |
DNA:missense mutations:cds:p.Q1236H, p.E1143G (33708G>T, 3428A>G) (human) DNA:missense mutation:cds:p.W748S, p.E1143G (2243G>C, 3428A>G) (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:18208989 PMID:20138553 PMID:25065347 PMID:30255931 |
RGD:15039297 RGD:15039302 |
NCBI chrNW_004936483:15,178,947...15,196,277
Ensembl chrNW_004936483:15,179,342...15,195,258
|
|
G |
Polr2g |
RNA polymerase II subunit G |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936581:523,018...528,167
Ensembl chrNW_004936581:522,950...528,933
|
|
G |
Pon1 |
paraoxonase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936585:4,954,871...4,979,560
Ensembl chrNW_004936585:4,954,869...4,979,591
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
LPS-induced acute liver damage CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:21262334 PMID:24385052 PMID:38181850 |
RGD:5509941 |
NCBI chrNW_004936629:3,672,445...3,725,645
Ensembl chrNW_004936629:3,672,460...3,725,626
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
ISO |
mRNA, protein:decreased expression:liver |
RGD |
PMID:26599535 |
RGD:11554658 |
NCBI chrNW_004936602:1,230,907...1,368,588
Ensembl chrNW_004936602:1,230,907...1,304,743
|
|
G |
Pptc7 |
protein phosphatase targeting COQ7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936558:3,491,225...3,531,886
Ensembl chrNW_004936558:3,490,808...3,532,345
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
treatment |
ISO |
|
RGD |
PMID:29091898 |
RGD:15090820 |
NCBI chrNW_004936518:1,817,051...1,843,376
Ensembl chrNW_004936518:1,804,969...1,843,380
|
|
G |
Prkcd |
protein kinase C delta |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30393195 |
|
NCBI chrNW_004936473:3,892,625...3,923,467
Ensembl chrNW_004936473:3,892,366...3,923,515
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224054 |
|
NCBI chrNW_004936590:4,722,914...4,887,615
Ensembl chrNW_004936590:4,722,873...4,890,156
|
|
G |
Ptf1a |
pancreas associated transcription factor 1a |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21182459 |
|
NCBI chrNW_004936520:4,978,896...4,980,648
Ensembl chrNW_004936520:4,978,896...4,980,648
|
|
G |
Ptges2 |
prostaglandin E synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31444509 |
|
NCBI chrNW_004936487:15,703,179...15,708,408
Ensembl chrNW_004936487:15,703,153...15,707,697
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:11743745 PMID:29091898 |
RGD:15090820 |
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Pum1 |
pumilio RNA binding family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936474:14,243,325...14,363,461
Ensembl chrNW_004936474:14,243,296...14,363,500
|
|
G |
Pygl |
glycogen phosphorylase L |
|
ISO |
protein:increased expression:serum (rat) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:25231249 PMID:25336395 |
RGD:21079733 |
NCBI chrNW_004936495:14,692,688...14,728,663
Ensembl chrNW_004936495:14,692,332...14,730,231
|
|
G |
Rasa1 |
RAS p21 protein activator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936469:5,839,560...5,933,049
Ensembl chrNW_004936469:5,839,743...5,932,021
|
|
G |
Rbp1 |
retinol binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936540:1,600,673...1,626,573
Ensembl chrNW_004936540:1,600,398...1,626,652
|
|
G |
Rdh13 |
retinol dehydrogenase 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27865848 |
|
NCBI chrNW_004936886:356,068...368,525
Ensembl chrNW_004936886:355,879...368,608
|
|
G |
Reep5 |
receptor accessory protein 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936531:7,055,841...7,103,810
Ensembl chrNW_004936531:7,053,039...7,104,288
|
|
G |
Rgn |
regucalcin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936502:12,872,938...12,891,270
Ensembl chrNW_004936502:12,872,824...12,891,506
|
|
G |
Ripk3 |
receptor interacting serine/threonine kinase 3 |
|
ISO |
protein:increased expression:liver (mouse) CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:26769846 PMID:28205631 |
RGD:127229945 |
NCBI chrNW_004936722:209,019...212,817
Ensembl chrNW_004936722:209,013...212,839
|
|
G |
Scarb1 |
scavenger receptor class B member 1 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:28959666 |
RGD:401794432 |
NCBI chrNW_004936558:530,828...555,098
Ensembl chrNW_004936558:530,828...552,892
|
|
G |
Selenbp1 |
selenium binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chrNW_004936580:1,573,208...1,584,266
Ensembl chrNW_004936580:1,573,150...1,581,921
|
|
G |
Sema4a |
semaphorin 4A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33290778 |
|
NCBI chrNW_004936580:5,404,380...5,431,183
Ensembl chrNW_004936580:5,406,194...5,431,185
|
|
G |
Senp2 |
SUMO specific peptidase 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29535048 |
|
NCBI chrNW_004936578:4,252,718...4,290,452
Ensembl chrNW_004936578:4,248,244...4,290,418
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO |
associated with precursor lymphoblastic lymphoma/leukemia;DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human) |
RGD |
PMID:23183238 |
RGD:14696750 |
NCBI chrNW_004936543:1,032,543...1,040,956
Ensembl chrNW_004936543:1,032,794...1,039,123
|
|
G |
Serping1 |
serpin family G member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936581:4,911,403...4,924,484
Ensembl chrNW_004936581:4,908,458...4,924,645
|
|
G |
Sesn2 |
sestrin 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28209544 |
|
NCBI chrNW_004936474:12,416,652...12,436,799
Ensembl chrNW_004936474:12,416,652...12,436,814
|
|
G |
Sgf29 |
SAGA complex associated factor 29 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936501:12,008,601...12,024,113
Ensembl chrNW_004936501:12,008,425...12,028,239
|
|
G |
Shc1 |
SHC adaptor protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 PMID:32659284 |
|
NCBI chrNW_004936580:4,511,560...4,522,003
Ensembl chrNW_004936580:4,512,680...4,519,715
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
|
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:28827769 |
RGD:15045609 |
NCBI chrNW_004936495:12,958,983...12,975,755
Ensembl chrNW_004936495:12,959,077...12,975,755
|
|
G |
Slc10a7 |
solute carrier family 10 member 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936535:2,792,576...3,038,504
Ensembl chrNW_004936535:2,792,293...3,038,512
|
|
G |
Slc13a4 |
solute carrier family 13 member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936592:450,237...497,050
Ensembl chrNW_004936592:454,191...497,090
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936581:319,372...343,171
Ensembl chrNW_004936581:319,260...343,300
|
|
G |
Slc25a29 |
solute carrier family 25 member 29 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936604:3,950,266...3,965,836
Ensembl chrNW_004936604:3,949,930...3,965,597
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
treatment |
ISO |
|
RGD |
PMID:9200186 |
RGD:151357001 |
NCBI chrNW_004936641:1,513,110...1,538,955
|
|
G |
Snx18 |
sorting nexin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chrNW_004936480:13,108,510...13,137,550
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 PMID:27349771 |
|
NCBI chrNW_004936500:10,345,154...10,352,873
Ensembl chrNW_004936500:10,345,154...10,352,867
|
|
G |
Sod2 |
superoxide dismutase 2 |
susceptibility treatment severity |
ISO |
DNA:SNP:cds:p.Val16Ala(human) associated with acute lymphoblastic leukemia;DNA:SNP: :(rs4880)(human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19332662 PMID:19647030 PMID:20578157 PMID:25226513 PMID:27019981 |
RGD:11060605 RGD:26923957 RGD:26923959 RGD:26923961 |
NCBI chrNW_004936489:11,178,338...11,191,601
Ensembl chrNW_004936489:11,178,015...11,191,781
|
|
G |
Sord |
sorbitol dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12763371 |
|
NCBI chrNW_004936471:7,760,097...7,805,475
Ensembl chrNW_004936471:7,760,052...7,795,671
|
|
G |
Sorl1 |
sortilin related receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936542:6,192,407...6,352,835
Ensembl chrNW_004936542:6,192,407...6,352,424
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chrNW_004936905:148,956...156,023
Ensembl chrNW_004936905:148,945...156,079
|
|
G |
Srp72 |
signal recognition particle 72 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936482:18,687,088...18,721,734
Ensembl chrNW_004936482:18,687,046...18,721,757
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:38460807 |
|
NCBI chrNW_004936490:17,119,189...17,178,402
Ensembl chrNW_004936490:17,117,290...17,178,402
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
severity |
ISO |
protein:increased phosphorylation:liver, inflammatory cell (mouse) mRNA:increased expression:liver, macrophage (mouse) |
RGD |
PMID:23876342 PMID:24731448 |
RGD:25671417 RGD:25671422 |
NCBI chrNW_004936506:7,091,982...7,185,938
Ensembl chrNW_004936506:7,095,009...7,184,689
|
|
G |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:36520315 |
|
NCBI chrNW_004936531:8,555,966...8,562,829
Ensembl chrNW_004936531:8,555,637...8,562,885
|
|
G |
Sult2b1 |
sulfotransferase family 2B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27052460 |
|
NCBI chrNW_004936664:2,626,810...2,655,290
Ensembl chrNW_004936664:2,626,764...2,655,340
|
|
G |
Suox |
sulfite oxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936646:411,543...415,709
Ensembl chrNW_004936646:411,084...415,732
|
|
G |
Tagln2 |
transgelin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936740:689,745...697,145
Ensembl chrNW_004936740:689,595...699,763
|
|
G |
Taldo1 |
transaldolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19436114 |
|
NCBI chrNW_004936888:531,002...540,194
Ensembl chrNW_004936888:531,020...540,820
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22206755 |
|
NCBI chrNW_004936588:2,040,712...2,044,635
Ensembl chrNW_004936588:2,040,630...2,045,110
|
|
G |
Tctn1 |
tectonic family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chrNW_004936558:3,552,909...3,581,212
Ensembl chrNW_004936558:3,552,864...3,581,368
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
treatment |
ISO |
|
RGD |
PMID:27516150 |
RGD:14995464 |
NCBI chrNW_004936661:3,742,080...3,758,266
Ensembl chrNW_004936661:3,742,066...3,758,272
|
|
G |
Tgfbr1 |
transforming growth factor beta receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28560358 |
|
NCBI chrNW_004936524:7,656,523...7,680,043
Ensembl chrNW_004936524:7,655,847...7,681,097
|
|
G |
Thbs1 |
thrombospondin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35357534 |
|
NCBI chrNW_004936471:3,064,466...3,081,125
Ensembl chrNW_004936471:3,064,422...3,081,949
|
|
G |
Thpo |
thrombopoietin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:33122006 |
|
NCBI chrNW_004936578:5,508,669...5,515,984
Ensembl chrNW_004936578:5,509,111...5,515,103
|
|
G |
Tlr4 |
toll like receptor 4 |
disease_progression |
ISO |
|
RGD |
PMID:17504260 |
RGD:14697733 |
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
|
|
G |
Tlr5 |
toll like receptor 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30508503 |
|
NCBI chrNW_004936526:383,490...387,007
Ensembl chrNW_004936526:383,418...401,552
|
|
G |
Tmed7 |
transmembrane p24 trafficking protein 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936742:779,964...791,738
Ensembl chrNW_004936742:745,336...791,883
|
|
G |
Tmem117 |
transmembrane protein 117 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936512:2,327,765...2,765,488
Ensembl chrNW_004936512:2,327,730...2,765,697
|
|
G |
Tmem164 |
transmembrane protein 164 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936499:5,042,638...5,199,433
|
|
G |
Tmem38b |
transmembrane protein 38B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936559:6,501,890...6,553,446
Ensembl chrNW_004936559:6,500,190...6,553,513
|
|
G |
Tnf |
tumor necrosis factor |
treatment severity |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic protein:increased expression:serum (rat) |
RGD CTD |
PMID:7532385 PMID:9309314 PMID:9696492 PMID:10801287 PMID:10801288 PMID:11124822 PMID:14686721 PMID:15830285 PMID:17070847 PMID:17709330 PMID:19638433 PMID:20623750 PMID:21984482 PMID:29091898 PMID:31077717 PMID:31342809 PMID:37866487 More...
|
RGD:10450531 RGD:14696804 RGD:14975281 RGD:14995429 RGD:14995432 RGD:14995435 RGD:14995437 RGD:14995485 RGD:15036799 RGD:15090820 |
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
G |
Trpm2 |
transient receptor potential cation channel subfamily M member 2 |
|
ISO |
|
RGD |
PMID:24569808 |
RGD:9999438 |
NCBI chrNW_004936500:21,960...76,895
Ensembl chrNW_004936500:21,942...77,260
|
|
G |
Ttr |
transthyretin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936682:1,628,489...1,635,495
Ensembl chrNW_004936682:1,628,341...1,635,566
|
|
G |
Tubb4b |
tubulin beta 4B class IVb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936669:749,203...751,622
Ensembl chrNW_004936669:749,202...751,739
|
|
G |
Uba5 |
ubiquitin like modifier activating enzyme 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936529:5,997,459...6,010,776
Ensembl chrNW_004936529:5,996,707...6,014,227
|
|
G |
Unc93b1 |
unc-93 homolog B1, TLR signaling regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936599:2,109,292...2,146,006
Ensembl chrNW_004936599:2,109,292...2,117,143
|
|
G |
Usp5 |
ubiquitin specific peptidase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936709:952,225...966,429
Ensembl chrNW_004936709:952,182...966,498
|
|
G |
Vegfa |
vascular endothelial growth factor A |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17784864 PMID:25231249 |
RGD:15003197 |
NCBI chrNW_004936476:16,245,134...16,261,180
Ensembl chrNW_004936476:16,247,100...16,260,673
|
|
G |
Vim |
vimentin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936520:10,051,692...10,059,324
Ensembl chrNW_004936520:10,052,012...10,059,182
|
|
G |
Vwf |
von Willebrand factor |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver: |
CTD RGD |
PMID:7531171 PMID:28527913 |
RGD:11079232 |
NCBI chrNW_004936709:1,578,137...1,741,877
Ensembl chrNW_004936709:1,579,096...1,741,754
|
|
G |
Wasl |
WASP like actin nucleation promoting factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936605:1,741,832...1,816,694
Ensembl chrNW_004936605:1,742,776...1,816,690
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
susceptibility |
ISO |
DNA:haploinsufficiency: : (mouse) |
RGD |
PMID:21737425 |
RGD:15036796 |
NCBI chrNW_004936706:752,571...783,746
Ensembl chrNW_004936706:751,108...783,777
|
|
G |
Xylb |
xylulokinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936473:27,725,955...27,767,319
Ensembl chrNW_004936473:27,725,937...27,767,102
|
|
G |
Zdhhc23 |
zinc finger DHHC-type palmitoyltransferase 23 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936536:1,434,774...1,450,872
Ensembl chrNW_004936536:1,434,748...1,450,854
|
|
|
G |
Arrb2 |
arrestin beta 2 |
|
ISO |
protein:increased expression:striatum |
RGD |
PMID:26174132 |
RGD:11534754 |
NCBI chrNW_004936677:3,173,054...3,181,475
Ensembl chrNW_004936677:3,172,925...3,181,520
|
|
G |
Drd2 |
dopamine receptor D2 |
|
ISO |
|
RGD |
PMID:26174132 |
RGD:11534754 |
NCBI chrNW_004936612:1,094,686...1,154,149
Ensembl chrNW_004936612:1,094,680...1,154,798
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
susceptibility |
ISO |
protein:decreased expression:prefrontal cortex associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human) |
RGD |
PMID:24200867 PMID:27967329 |
RGD:401900122 RGD:401900162 |
NCBI chrNW_004936509:1,160,559...1,201,037
Ensembl chrNW_004936509:1,161,094...1,201,576
|
|
G |
Gad2 |
glutamate decarboxylase 2 |
susceptibility |
ISO |
associated with amphetamine abuse; DNA:SNP: :rs2236418(human) |
RGD |
PMID:27967329 |
RGD:401900122 |
NCBI chrNW_004936484:1,737,806...1,810,378
Ensembl chrNW_004936484:1,737,520...1,810,398
|
|
G |
Oprm1 |
opioid receptor mu 1 |
|
ISO |
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human) |
RGD |
PMID:16402083 |
RGD:401827939 |
NCBI chrNW_004936489:6,506,207...6,567,136
Ensembl chrNW_004936489:6,506,207...6,548,946
|
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
|
ISO |
|
RGD |
PMID:6445277 PMID:7740056 |
RGD:10047091 RGD:1598524 |
NCBI chrNW_004936530:7,543,743...7,621,392
Ensembl chrNW_004936530:7,543,682...7,622,667
|
|
G |
Cacna1d |
calcium voltage-gated channel subunit alpha1 D |
|
ISO |
|
RGD |
PMID:18947822 |
RGD:6906919 |
NCBI chrNW_004936473:4,164,633...4,479,866
Ensembl chrNW_004936473:4,037,533...4,478,073
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19109989 |
|
NCBI chrNW_004936533:3,601,270...3,637,128
Ensembl chrNW_004936533:3,600,955...3,637,422
|
|
G |
Cck |
cholecystokinin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:2320253 |
|
NCBI chrNW_004936695:2,776,705...2,782,280
Ensembl chrNW_004936695:2,776,831...2,782,061
|
|
G |
Comt |
catechol-O-methyltransferase |
|
ISO |
|
RGD |
PMID:16437585 |
RGD:2289781 |
NCBI chrNW_004936619:3,847,059...3,883,866
Ensembl chrNW_004936619:3,876,299...3,882,747
|
|
G |
Dbn1 |
drebrin 1 |
|
ISO |
levodopainduced; protein:increased expression:striatum: |
RGD |
PMID:23241013 |
RGD:10398811 |
NCBI chrNW_004936597:1,735,589...1,751,628
Ensembl chrNW_004936597:1,735,380...1,747,569
|
|
G |
Ddc |
dopa decarboxylase |
|
ISO |
associated with Parkinson Disease; protein:decreased expression:striatum (rat) |
RGD |
PMID:20232137 |
RGD:5128860 |
NCBI chrNW_004936686:1,322,153...1,405,434
Ensembl chrNW_004936686:1,301,207...1,405,384
|
|
G |
Drd1 |
dopamine receptor D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7845605 PMID:10858612 PMID:16982285 PMID:19520364 |
|
NCBI chrNW_004936609:790,647...795,187
Ensembl chrNW_004936609:792,276...793,613
|
|
G |
Drd2 |
dopamine receptor D2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:7845605 PMID:10534246 PMID:14629710 PMID:18707801 |
RGD:2311579 |
NCBI chrNW_004936612:1,094,686...1,154,149
Ensembl chrNW_004936612:1,094,680...1,154,798
|
|
G |
Drd3 |
dopamine receptor D3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20945430 |
|
NCBI chrNW_004936536:1,580,732...1,616,726
Ensembl chrNW_004936536:1,580,732...1,616,725
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
|
RGD |
PMID:22153973 |
RGD:10395307 |
NCBI chrNW_004936531:7,625,956...7,629,041
Ensembl chrNW_004936531:7,625,892...7,629,749
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17219962 |
|
NCBI chrNW_004936706:1,900,954...1,907,567
Ensembl chrNW_004936706:1,900,931...1,906,772
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9767399 |
|
NCBI chrNW_004936509:1,160,559...1,201,037
Ensembl chrNW_004936509:1,161,094...1,201,576
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15659429 |
|
NCBI chrNW_004936697:232,048...275,420
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11168568 |
|
NCBI chrNW_004936518:4,291,391...4,310,752
Ensembl chrNW_004936518:4,288,154...4,310,753
|
|
G |
Glul |
glutamate-ammonia ligase |
|
ISO |
|
RGD |
PMID:6445277 |
RGD:10047091 |
NCBI chrNW_004936481:7,293,301...7,301,416
Ensembl chrNW_004936481:7,293,091...7,306,202
|
|
G |
Grk6 |
G protein-coupled receptor kinase 6 |
|
ISO |
associated with Parkinson Disease |
RGD |
PMID:20410529 |
RGD:5684919 |
NCBI chrNW_004936597:1,706,671...1,722,370
Ensembl chrNW_004936597:1,706,665...1,722,370
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
treatment |
ISO |
associated with Parkinsonian Disorders |
RGD |
PMID:26997328 |
RGD:13792768 |
NCBI chrNW_004936536:6,730,070...6,893,818
Ensembl chrNW_004936536:6,730,062...6,894,303
|
|
G |
Homer1 |
homer scaffold protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24126708 |
|
NCBI chrNW_004936549:7,189,588...7,320,117
Ensembl chrNW_004936549:7,188,850...7,320,312
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
|
ISO |
|
RGD |
PMID:21352823 |
RGD:5683628 |
NCBI chrNW_004936480:5,042,531...5,047,157
Ensembl chrNW_004936480:5,043,204...5,044,472
|
|
G |
LOC101961588 |
cytochrome P450 2D17 |
|
ISO |
|
RGD |
PMID:12629505 |
RGD:1358549 |
NCBI chrNW_004936718:153,340...157,966
|
|
G |
Mapt |
microtubule associated protein tau |
treatment |
ISO |
associated with Parkinsonian Disorders |
RGD |
PMID:25511986 |
RGD:13800920 |
NCBI chrNW_004936541:2,381,411...2,479,984
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
treatment |
ISO |
associated with Parkinsonian Disorders |
RGD |
PMID:23938307 |
RGD:10040953 |
NCBI chrNW_004936474:158,376...282,310
Ensembl chrNW_004936474:157,590...282,342
|
|
G |
Pdyn |
prodynorphin |
severity treatment |
ISO |
CTD Direct Evidence: marker/mechanism associated with Parkinsonism;protein:increased expression:striatum |
CTD RGD |
PMID:9767399 PMID:10869049 PMID:17884291 PMID:21737418 |
RGD:401850563 RGD:401851046 RGD:401900134 |
NCBI chrNW_004936485:16,559,371...16,571,461
Ensembl chrNW_004936485:16,559,217...16,571,678
|
|
G |
Penk |
proenkephalin |
disease_progression treatment |
ISO |
mRNA:increased expression:brain:striatum: associated with Parkinsonism;mRNA:increased expression:striatum CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:9767399 PMID:10869049 PMID:20456008 PMID:26113400 |
RGD:10003039 RGD:401851054 RGD:401900134 |
NCBI chrNW_004936496:3,016,247...3,021,726
Ensembl chrNW_004936496:3,016,218...3,021,738
|
|
G |
Ppp1r1b |
protein phosphatase 1 regulatory inhibitor subunit 1B |
treatment |
ISO |
associated with Parkinsonian Disorders |
RGD |
PMID:27771532 |
RGD:13514053 |
NCBI chrNW_004936490:14,822,246...14,831,337
Ensembl chrNW_004936490:14,822,213...14,831,349
|
|
G |
Rasgrf1 |
Ras protein specific guanine nucleotide releasing factor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21115823 |
|
NCBI chrNW_004936471:37,173,595...37,278,356
Ensembl chrNW_004936471:37,171,297...37,278,529
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
protein:increased expression:nucleus, brain |
RGD |
PMID:18590723 |
RGD:2298778 |
NCBI chrNW_004936599:3,800,142...3,810,583
Ensembl chrNW_004936599:3,801,636...3,809,813
|
|
G |
Rgs4 |
regulator of G protein signaling 4 |
treatment |
ISO |
associated with Parkinsonian Disorders |
RGD |
PMID:24969021 |
RGD:13524515 |
NCBI chrNW_004937238:101,948...109,513
Ensembl chrNW_004937238:102,061...109,474
|
|
G |
Rgs9 |
regulator of G protein signaling 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:18160641 PMID:24663062 |
|
NCBI chrNW_004936541:7,472,195...7,525,220
Ensembl chrNW_004936541:7,458,539...7,525,220
|
|
G |
Th |
tyrosine hydroxylase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15659429 |
|
NCBI chrNW_004936794:478,651...486,887
Ensembl chrNW_004936794:478,614...487,061
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
susceptibility no_association |
ISO |
DNA:polymorphisms,haplotype:promoter:g.-1774delG,g.-1549G>A(human) DNA:SNPs:multiple: |
RGD |
PMID:17502832 PMID:22178260 |
RGD:14700816 RGD:14700817 |
NCBI chrNW_004936636:292,631...341,999
Ensembl chrNW_004936636:292,709...340,393
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
|
RGD |
PMID:16140414 |
RGD:2316848 |
NCBI chrNW_004936549:1,378,536...1,400,501
Ensembl chrNW_004936549:1,378,736...1,400,532
|
|
G |
LOC101973029 |
cytochrome P450 2E1 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:23619520 |
RGD:14700910 |
NCBI chrNW_004936486:19,691,822...19,702,684
Ensembl chrNW_004936486:19,691,822...19,702,102
|
|
G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
ISO |
protein:increased expression:liver (mouse) |
RGD |
PMID:12201952 |
RGD:10054288 |
NCBI chrNW_004936559:2,187,791...2,331,587
Ensembl chrNW_004936559:2,259,420...2,332,806
|
|
|
G |
Abcd1 |
ATP binding cassette subfamily D member 1 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:615,133...634,618
Ensembl chrNW_004936809:615,139...635,990
|
|
G |
Arhgap4 |
Rho GTPase activating protein 4 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:791,275...807,448
Ensembl chrNW_004936809:791,274...807,450
|
|
G |
Atp2b3 |
ATPase plasma membrane Ca2+ transporting 3 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936809:396,883...466,372
Ensembl chrNW_004936809:396,733...466,524
|
|
G |
Atp6ap1 |
ATPase H+ transporting accessory protein 1 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,179,507...1,188,172
Ensembl chrNW_004936809:1,179,464...1,188,283
|
|
G |
Avpr2 |
arginine vasopressin receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:789,337...790,986
Ensembl chrNW_004936809:788,286...790,954
|
|
G |
Bcap31 |
B cell receptor associated protein 31 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:582,689...614,800
Ensembl chrNW_004936809:582,649...615,079
|
|
G |
Bgn |
biglycan |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936809:375,589...389,718
Ensembl chrNW_004936809:375,543...389,756
|
|
G |
Brcc3 |
BRCA1/BRCA2-containing complex subunit 3 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936927:341,114...380,817
Ensembl chrNW_004936927:341,253...376,700
|
|
G |
Ccnq |
cyclin Q |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936809:471,619...482,296
Ensembl chrNW_004936809:472,061...482,192
|
|
G |
Clic2 |
chloride intracellular channel 2 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936927:514,989...543,691
Ensembl chrNW_004936927:514,899...543,693
|
|
G |
Cmc4 |
C-X9-C motif containing 4 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936927:317,417...341,016
Ensembl chrNW_004936927:320,833...341,021
|
|
G |
Dkc1 |
dyskerin pseudouridine synthase 1 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936927:134,770...144,057
|
|
G |
Dnase1l1 |
deoxyribonuclease 1 like 1 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,151,312...1,159,017
Ensembl chrNW_004936809:1,151,202...1,159,029
|
|
G |
Dusp9 |
dual specificity phosphatase 9 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936809:535,434...538,219
Ensembl chrNW_004936809:535,434...539,319
|
|
G |
Emd |
emerin |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,127,701...1,130,195
Ensembl chrNW_004936809:1,127,710...1,130,195
|
|
G |
F8 |
coagulation factor VIII |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936927:189,359...301,791
Ensembl chrNW_004936927:190,111...301,609
|
|
G |
F8a1 |
coagulation factor VIII associated 1 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936927:234,162...236,881
|
|
G |
Fam3a |
FAM3 metabolism regulating signaling molecule A |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,248,865...1,258,894
Ensembl chrNW_004936809:1,249,823...1,258,860
|
|
G |
Fam50a |
family with sequence similarity 50 member A |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,195,479...1,202,126
|
|
G |
Flna |
filamin A |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,097,288...1,123,206
Ensembl chrNW_004936809:1,097,294...1,123,201
|
|
G |
Fundc2 |
FUN14 domain containing 2 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936927:304,162...318,271
Ensembl chrNW_004936927:304,197...318,271
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency | ClinVar Annotator: match by term: FAVISM, SUSCEPTIBILITY TO | ClinVar Annotator: match by term: Favism, susceptibility to | ClinVar Annotator: match by term: G6PD A- | ClinVar Annotator: match by term: G6PD MALAGA | ClinVar Annotator: match by term: G6PD MINNESOTA | ClinVar Annotator: match by term: G6PD SANTIAGO | ClinVar Annotator: match by term: G6PD SANTIAGO DE CUBA | ClinVar Annotator: match by term: G6PD SERRES |
ClinVar |
PMID:5448 PMID:16832 PMID:511159 PMID:736032 PMID:835572 PMID:848857 PMID:853376 PMID:1008056 PMID:1270075 PMID:1303173 PMID:1303182 PMID:1459579 PMID:1536798 PMID:1551674 PMID:1562739 PMID:1611091 PMID:1631957 PMID:1805484 PMID:1879833 PMID:1924316 PMID:1945893 PMID:1953767 PMID:1972698 PMID:1978554 PMID:1978555 PMID:1999339 PMID:1999409 PMID:2157298 PMID:2190319 PMID:2222408 PMID:2253938 PMID:2255919 PMID:2263506 PMID:2307454 PMID:2321910 PMID:2393028 PMID:2503817 PMID:2572288 PMID:2602358 PMID:2606066 PMID:2633878 PMID:2836867 PMID:2849540 PMID:2895981 PMID:2912069 PMID:2912886 PMID:3198117 PMID:3201886 PMID:3338798 PMID:3393536 PMID:3446582 PMID:3565372 PMID:3591235 PMID:3740052 PMID:4154774 PMID:4283789 PMID:4359638 PMID:4379606 PMID:4388132 PMID:4392654 PMID:4435794 PMID:4721339 PMID:4837298 PMID:4838696 PMID:4974311 PMID:5081671 PMID:5305539 PMID:5316621 PMID:5369703 PMID:5413384 PMID:5485383 PMID:5641629 PMID:5673160 PMID:5770172 PMID:5775246 PMID:5779160 PMID:5844610 PMID:6015571 PMID:6344088 PMID:6500558 PMID:6698555 PMID:6714978 PMID:6714986 PMID:6805883 PMID:7055648 PMID:7129446 PMID:7160841 PMID:7203486 PMID:7211845 PMID:7327562 PMID:7390473 PMID:7440223 PMID:7577654 PMID:7590755 PMID:7655862 PMID:7789945 PMID:7803800 PMID:7806085 PMID:7825590 PMID:7849299 PMID:7858267 PMID:7870632 PMID:7947239 PMID:7947250 PMID:7949118 PMID:7959686 PMID:7959695 PMID:8118045 PMID:8141125 PMID:8193373 PMID:8241497 PMID:8244337 PMID:8364584 PMID:8370579 PMID:8436389 PMID:8447319 PMID:8471773 PMID:8477268 PMID:8490627 PMID:8533762 PMID:8537082 PMID:8611726 PMID:8807085 PMID:8807321 PMID:8807322 PMID:8813094 PMID:8956035 PMID:9017974 PMID:9192788 PMID:9233561 PMID:9250351 PMID:9290617 PMID:9298828 PMID:9299858 PMID:9332310 PMID:9342374 PMID:9384614 PMID:9410474 PMID:9444913 PMID:9536098 PMID:9589612 PMID:9674740 PMID:9858856 PMID:10192449 PMID:10221015 PMID:10480214 PMID:10502785 PMID:10556177 PMID:10571945 PMID:10627140 PMID:10643148 PMID:10666231 PMID:10734064 PMID:10772881 PMID:10782016 PMID:10916676 PMID:11024211 PMID:11042039 PMID:11112389 PMID:11146567 PMID:11243133 PMID:11261779 PMID:11271380 PMID:11295127 PMID:11379875 PMID:11400791 PMID:11445808 PMID:11484161 PMID:11499668 PMID:11594515 PMID:11601226 PMID:11748843 PMID:11780463 PMID:11793482 PMID:11852882 PMID:11968085 PMID:12028056 PMID:12064901 PMID:12064902 PMID:12064920 PMID:12105841 PMID:12130518 PMID:12187030 PMID:12215013 PMID:12367584 PMID:12497642 PMID:12737938 PMID:12737940 PMID:12768444 PMID:12850494 PMID:14014720 PMID:14278484 PMID:14505231 PMID:14757424 PMID:14757426 PMID:15065213 PMID:15223006 PMID:15315792 PMID:15349799 PMID:15466166 PMID:15502081 PMID:15625830 PMID:15727905 PMID:15766741 PMID:15858258 PMID:15906717 PMID:15914531 PMID:15996881 PMID:16079115 PMID:16088936 PMID:16119988 PMID:16136268 PMID:16143877 PMID:16155737 PMID:16193512 PMID:16329560 PMID:16356170 PMID:16427346 PMID:16461316 PMID:16513531 PMID:16528451 PMID:16601897 PMID:16607506 PMID:16753852 PMID:16777444 PMID:16927025 PMID:16934959 PMID:16944148 PMID:17018380 PMID:17233850 PMID:17524386 PMID:17576681 PMID:17587269 PMID:17611006 PMID:17726510 PMID:17877203 PMID:17959407 PMID:18043863 PMID:18046504 PMID:18056001 PMID:18066402 PMID:18086567 PMID:18177777 PMID:18226470 PMID:18270558 PMID:18329300 PMID:18452027 PMID:18568599 PMID:18627054 PMID:18677765 PMID:19224086 PMID:19396829 PMID:19422023 PMID:19465117 PMID:19589177 PMID:19594365 PMID:19632868 PMID:19846429 PMID:20007901 PMID:20052779 PMID:20085579 PMID:20200584 PMID:20203002 PMID:20236109 PMID:20582980 PMID:20602793 PMID:20621077 PMID:20713184 PMID:20949590 PMID:21063220 PMID:21153663 PMID:21302115 PMID:21397531 PMID:21441392 PMID:21446359 PMID:21479984 PMID:21507207 PMID:21637675 PMID:21677401 PMID:21874587 PMID:21931771 PMID:21989994 PMID:22018328 PMID:22139979 PMID:22164279 PMID:22165289 PMID:22171972 PMID:22237549 PMID:22281021 PMID:22293322 PMID:22307442 PMID:22382802 PMID:22452742 PMID:22552160 PMID:22770933 PMID:22906047 PMID:22906837 PMID:22963789 PMID:22963798 PMID:23006493 PMID:23057857 PMID:23144702 PMID:23365477 PMID:23389243 PMID:23409742 PMID:23479361 PMID:23660394 PMID:23757202 PMID:23926329 PMID:23965028 PMID:24022758 PMID:24033266 PMID:24117340 PMID:24134566 PMID:24365856 PMID:24460025 PMID:24505519 PMID:24551785 PMID:24586352 PMID:24711023 PMID:24787449 PMID:24962355 PMID:25071003 PMID:25141282 PMID:25189226 PMID:25201310 PMID:25326637 PMID:25407525 PMID:25440321 PMID:25536053 PMID:25541721 PMID:25548459 PMID:25741868 PMID:25775246 PMID:25925739 PMID:26060661 PMID:26226515 PMID:26275698 PMID:26479991 PMID:26633385 PMID:26693676 PMID:26823837 PMID:26827633 PMID:26829728 PMID:26990548 PMID:27040960 PMID:27053284 PMID:27213370 PMID:27282571 PMID:27287612 PMID:27408423 PMID:27495838 PMID:27519946 PMID:27535533 PMID:27853304 PMID:27880809 PMID:27884173 PMID:27914961 PMID:27941691 PMID:27980749 PMID:28028996 PMID:28059001 PMID:28195434 PMID:28356147 PMID:28492532 PMID:28512736 PMID:28583873 PMID:28756180 PMID:28824188 PMID:28852037 PMID:29072585 PMID:29138396 PMID:29141760 PMID:29248304 PMID:29300386 PMID:29333274 PMID:29339739 PMID:29396846 PMID:30045279 PMID:30077011 PMID:30096395 PMID:30097005 PMID:30161219 PMID:30314477 PMID:30315739 PMID:30674319 PMID:30988594 PMID:31294066 PMID:31489982 PMID:31525211 PMID:31590661 PMID:31602632 PMID:31609781 PMID:31833391 PMID:31862010 PMID:31863082 PMID:32156605 PMID:32180910 PMID:32387441 PMID:32387609 PMID:32425388 PMID:32641076 PMID:32680472 PMID:32702756 PMID:32860008 PMID:32987391 PMID:33051526 PMID:33069889 PMID:33072997 PMID:33128437 PMID:33413378 PMID:33536406 PMID:33628497 PMID:33636823 PMID:33637102 PMID:33708821 PMID:34007417 PMID:34134107 PMID:34272389 PMID:34532700 PMID:34551338 PMID:34620237 PMID:34643346 PMID:34659341 PMID:34762759 PMID:34895177 PMID:34934109 PMID:34966093 PMID:34989400 PMID:35313968 PMID:35384376 PMID:35606495 PMID:35695473 PMID:35753512 PMID:35840819 PMID:35845714 PMID:36089067 PMID:36150187 PMID:36212124 PMID:36212142 PMID:36315991 PMID:36353116 PMID:36681081 PMID:36703223 PMID:36704359 PMID:36949502 PMID:38066190 PMID:38308253 PMID:38645242 PMID:38970298 More...
|
|
NCBI chrNW_004936809:1,269,900...1,285,853
Ensembl chrNW_004936809:1,269,914...1,285,889
|
|
G |
Gab3 |
GRB2 associated binding protein 3 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936927:68,506...93,899
Ensembl chrNW_004936927:70,923...124,164
|
|
G |
Gdi1 |
GDP dissociation inhibitor 1 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,188,793...1,194,816
Ensembl chrNW_004936809:1,188,628...1,194,863
|
|
G |
Haus7 |
HAUS augmin like complex subunit 7 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936809:321,906...350,105
Ensembl chrNW_004936809:321,497...350,110
|
|
G |
Hcfc1 |
host cell factor C1 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:827,008...853,689
Ensembl chrNW_004936809:827,031...853,644
|
|
G |
Idh3g |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:666,231...675,279
Ensembl chrNW_004936809:666,337...675,214
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency | ClinVar Annotator: match by term: G6PD A- |
ClinVar |
PMID:1945893 PMID:3198117 PMID:6805883 PMID:7803800 PMID:8244337 PMID:8471773 PMID:9384614 PMID:9589612 PMID:10480214 PMID:10502785 PMID:10627140 PMID:11379875 PMID:11601226 PMID:11748843 PMID:11968085 PMID:12064920 PMID:15727905 PMID:16329560 PMID:16427346 PMID:16601897 PMID:16607506 PMID:18046504 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19589177 PMID:19846429 PMID:21446359 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:25741868 PMID:28492532 PMID:29300386 PMID:29339739 PMID:30045279 PMID:30315739 PMID:31489982 PMID:31862010 PMID:31863082 PMID:33051526 PMID:33072997 PMID:34620237 PMID:34659341 PMID:34762759 PMID:34895177 PMID:34989400 PMID:35313968 PMID:35384376 PMID:35840819 PMID:36212142 PMID:36353116 More...
|
|
NCBI chrNW_004936809:1,280,254...1,306,964
Ensembl chrNW_004936809:1,257,654...1,301,813
|
|
G |
Irak1 |
interleukin 1 receptor associated kinase 1 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:891,407...900,311
Ensembl chrNW_004936809:890,717...900,326
|
|
G |
L1cam |
L1 cell adhesion molecule |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:736,385...768,822
Ensembl chrNW_004936809:736,319...761,973
|
|
G |
Lage3 |
L antigen family member 3 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,229,933...1,232,448
|
|
G |
LOC101967165 |
histone H2A-Bbd type 2/3 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936927:232,353...232,857
|
|
G |
Mecp2 |
methyl-CpG binding protein 2 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:902,938...967,771
Ensembl chrNW_004936809:911,764...966,839
|
|
G |
Mpp1 |
MAGUK p55 scaffold protein 1 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936927:147,448...170,435
Ensembl chrNW_004936927:147,282...170,575
|
|
G |
Mtcp1 |
mature T cell proliferation 1 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936927:334,017...341,016
Ensembl chrNW_004936927:334,894...341,072
|
|
G |
Naa10 |
N-alpha-acetyltransferase 10, NatA catalytic subunit |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:812,454...817,226
Ensembl chrNW_004936809:812,390...817,288
|
|
G |
Nsdhl |
NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936714:246,574...273,930
Ensembl chrNW_004936714:246,551...273,912
|
|
G |
Pdzd4 |
PDZ domain containing 4 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:681,412...707,932
Ensembl chrNW_004936809:679,938...707,938
|
|
G |
Plxna3 |
plexin A3 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,209,787...1,226,726
Ensembl chrNW_004936809:1,209,743...1,226,728
|
|
G |
Plxnb3 |
plexin B3 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:645,569...659,850
Ensembl chrNW_004936809:644,049...659,859
|
|
G |
Pnck |
pregnancy up-regulated nonubiquitous CaM kinase |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936809:553,438...557,385
Ensembl chrNW_004936809:553,431...557,427
|
|
G |
Pnma3 |
PNMA family member 3 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936714:90,133...93,805
Ensembl chrNW_004936714:92,269...93,660
|
|
G |
Pnma5 |
PNMA family member 5 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936714:155,618...156,955
Ensembl chrNW_004936714:155,618...157,563
|
|
G |
Pnma6a |
PNMA family member 6A |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936714:76,508...79,485
Ensembl chrNW_004936714:77,885...79,336
|
|
G |
Pnma6e |
PNMA family member 6E |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936809:266,367...269,248
|
|
G |
Rab39b |
RAB39B, member RAS oncogene family |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936927:492,114...498,030
Ensembl chrNW_004936927:492,099...498,294
|
|
G |
Renbp |
renin binding protein |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:817,392...823,926
Ensembl chrNW_004936809:817,355...823,941
|
|
G |
Rpl10 |
ribosomal protein L10 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,146,994...1,149,573
Ensembl chrNW_004936809:1,146,809...1,149,618
|
|
G |
Slc10a3 |
solute carrier family 10 member 3 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,241,980...1,245,986
Ensembl chrNW_004936809:1,241,986...1,246,266
|
|
G |
Slc6a8 |
solute carrier family 6 member 8 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:571,234...578,298
|
|
G |
Smim9 |
small integral membrane protein 9 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936927:171,867...186,718
|
|
G |
Srpk3 |
SRSF protein kinase 3 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:661,264...666,198
Ensembl chrNW_004936809:661,264...666,188
|
|
G |
Ssr4 |
signal sequence receptor subunit 4 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:675,178...679,245
Ensembl chrNW_004936809:675,049...679,707
|
|
G |
Tafazzin |
tafazzin, phospholipid-lysophospholipid transacylase |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,160,265...1,168,956
Ensembl chrNW_004936809:1,160,247...1,171,097
|
|
G |
Tex28 |
testis expressed 28 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,022,795...1,042,475
Ensembl chrNW_004936809:1,022,795...1,040,120
|
|
G |
Tktl1 |
transketolase like 1 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,048,672...1,084,125
Ensembl chrNW_004936809:1,048,672...1,083,994
|
|
G |
Trex2 |
three prime repair exonuclease 2 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936809:317,655...319,293
Ensembl chrNW_004936809:318,548...319,258
|
|
G |
Ubl4a |
ubiquitin like 4A |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
|
|
NCBI chrNW_004936809:1,238,459...1,241,319
Ensembl chrNW_004936809:1,238,462...1,241,318
|
|
G |
Vbp1 |
VHL binding protein 1 |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936927:433,598...468,191
Ensembl chrNW_004936927:433,551...469,331
|
|
G |
Zfp92 |
ZFP92 zinc finger protein |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936809:294,114...309,368
Ensembl chrNW_004936809:301,482...356,094
|
|
G |
Znf185 |
zinc finger protein 185 with LIM domain |
|
ISO |
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency |
ClinVar |
PMID:18177777 PMID:28492532 |
|
NCBI chrNW_004936714:167,552...218,785
Ensembl chrNW_004936714:152,319...218,921
|
|
|
G |
Ank3 |
ankyrin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29109170 |
|
NCBI chrNW_004936614:2,664,594...2,976,174
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
|
RGD |
PMID:15007105 |
RGD:12904641 |
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G |
C3 |
complement C3 |
|
ISO |
protein:increased activity:blood |
RGD |
PMID:30657461 |
RGD:408418720 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
C5 |
complement C5 |
|
ISO |
protein:increased activity:blood |
RGD |
PMID:30657461 |
RGD:408418720 |
NCBI chrNW_004936487:9,391,774...9,474,168
Ensembl chrNW_004936487:9,391,804...9,474,159
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26074427 |
|
NCBI chrNW_004936533:3,601,270...3,637,128
Ensembl chrNW_004936533:3,600,955...3,637,422
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
sexual_dimorphism |
ISO |
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat) |
RGD |
PMID:29251811 |
RGD:401965484 |
NCBI chrNW_004936541:2,288,847...2,333,129
Ensembl chrNW_004936541:2,288,841...2,331,689
|
|
G |
Dio3 |
iodothyronine deiodinase 3 |
treatment |
ISO |
|
RGD |
PMID:23763370 |
RGD:13432044 |
NCBI chrNW_004936604:5,241,877...5,243,910
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
mRNA,protein:increased expression:Pituitary gland (rat) |
RGD |
PMID:26509893 |
RGD:11344152 |
NCBI chrNW_004936659:520,181...565,496
Ensembl chrNW_004936659:520,493...565,416
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
|
ISO |
mRNA:increased expression:pituitary gland (rat) |
RGD |
PMID:26509893 |
RGD:11344152 |
NCBI chrNW_004936485:19,547,836...19,570,716
|
|
G |
Drd2 |
dopamine receptor D2 |
|
ISO |
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat) |
RGD |
PMID:26509893 PMID:28710248 |
RGD:11344152 RGD:401960105 |
NCBI chrNW_004936612:1,094,686...1,154,149
Ensembl chrNW_004936612:1,094,680...1,154,798
|
|
G |
Ehmt2 |
euchromatic histone lysine methyltransferase 2 |
|
ISO |
mRNA:increased expression:pituitary gland (rat) |
RGD |
PMID:26509893 |
RGD:11344152 |
NCBI chrNW_004936727:1,648,451...1,663,294
Ensembl chrNW_004936727:1,648,448...1,663,455
|
|
G |
Gabrb3 |
gamma-aminobutyric acid type A receptor subunit beta3 |
sexual_dimorphism treatment |
ISO |
in male mice only; mRNA:increased expression:frontal cortex: |
RGD |
PMID:23763370 PMID:30312858 |
RGD:13432044 RGD:405866345 |
NCBI chrNW_004936471:39,791,633...40,193,049
Ensembl chrNW_004936471:39,791,613...40,187,923
|
|
G |
Gabrg2 |
gamma-aminobutyric acid type A receptor subunit gamma2 |
|
ISO |
mRNA:increased expression:posterior hypothalamic region (rat) |
RGD |
PMID:18514412 |
RGD:402528884 |
NCBI chrNW_004936515:1,609,370...1,670,412
Ensembl chrNW_004936515:1,607,722...1,671,336
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
treatment |
ISO |
|
RGD |
PMID:22037411 PMID:23763370 |
RGD:13210751 RGD:13432044 |
NCBI chrNW_004936587:3,406,055...3,806,956
Ensembl chrNW_004936587:3,405,698...3,804,664
|
|
G |
Hdac2 |
histone deacetylase 2 |
|
ISO |
mRNA,protein:increased expression:pituitary gland (rat) |
RGD |
PMID:26509893 |
RGD:11344152 |
NCBI chrNW_004936679:2,448,676...2,474,641
Ensembl chrNW_004936679:2,448,390...2,474,641
|
|
G |
Hdac4 |
histone deacetylase 4 |
|
ISO |
mRNA,protein:increased expression:pituitary gland (rat) |
RGD |
PMID:26509893 |
RGD:11344152 |
NCBI chrNW_004936745:1,730,743...1,942,071
Ensembl chrNW_004936745:1,730,694...1,942,074
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
ISO |
protein:increased expression:placenta (rat) |
RGD |
PMID:26342748 |
RGD:401965481 |
NCBI chrNW_004936475:17,882,663...17,888,708
Ensembl chrNW_004936475:17,882,575...17,887,748
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
mRNA:decreased expression:cerebellum (rat) |
RGD |
PMID:16909201 |
RGD:12904886 |
NCBI chrNW_004936492:11,709,623...11,784,028
Ensembl chrNW_004936492:11,709,222...11,778,351
|
|
G |
Igf1r |
insulin like growth factor 1 receptor |
|
ISO |
protein:decreased activity:cerebellum (rat) |
RGD |
PMID:16909201 |
RGD:12904886 |
NCBI chrNW_004936483:4,563,995...4,860,231
Ensembl chrNW_004936483:4,564,512...4,852,925
|
|
G |
Mat2a |
methionine adenosyltransferase 2A |
|
ISO |
mRNA:decreased expression:brain (rat) |
RGD |
PMID:26180184 |
RGD:11074449 |
NCBI chrNW_004936712:1,710,513...1,717,339
Ensembl chrNW_004936712:1,709,716...1,717,499
|
|
G |
Mecp2 |
methyl-CpG binding protein 2 |
treatment |
ISO |
mRNA:increased expression:pituitary gland (rat) |
RGD |
PMID:23763370 PMID:26509893 |
RGD:11344152 RGD:13432044 |
NCBI chrNW_004936809:902,938...967,771
Ensembl chrNW_004936809:911,764...966,839
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
ISO |
mRNA:decreased expression:brain (rat) |
RGD |
PMID:26180184 |
RGD:11074449 |
NCBI chrNW_004936484:16,087,924...16,180,089
Ensembl chrNW_004936484:16,087,923...16,180,148
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25511929 |
|
NCBI chrNW_004936558:5,162,471...5,302,488
Ensembl chrNW_004936558:5,233,459...5,301,414
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3 group C member 2 |
sexual_dimorphism |
ISO |
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat) |
RGD |
PMID:29251811 |
RGD:401965484 |
NCBI chrNW_004936535:1,139,687...1,467,469
Ensembl chrNW_004936535:1,140,178...1,467,471
|
|
G |
Oprk1 |
opioid receptor kappa 1 |
|
ISO |
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex |
RGD |
PMID:29678771 |
RGD:401851055 |
NCBI chrNW_004936496:280,593...305,900
Ensembl chrNW_004936496:280,558...305,904
|
|
G |
Oprl1 |
opioid related nociceptin receptor 1 |
|
ISO |
mRNA:decreased expression:ventral tegmental area |
RGD |
PMID:29678771 |
RGD:401851055 |
NCBI chrNW_004936514:11,264,392...11,273,584
Ensembl chrNW_004936514:11,258,335...11,273,592
|
|
G |
Pdyn |
prodynorphin |
|
ISO |
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens |
RGD |
PMID:29678771 |
RGD:401851055 |
NCBI chrNW_004936485:16,559,371...16,571,461
Ensembl chrNW_004936485:16,559,217...16,571,678
|
|
G |
Per2 |
period circadian regulator 2 |
treatment |
ISO |
|
RGD |
PMID:31329297 |
RGD:405878078 |
NCBI chrNW_004936525:221,601...263,284
Ensembl chrNW_004936525:221,510...263,295
|
|
G |
Pnoc |
prepronociceptin |
|
ISO |
mRNA:increased expression:nucleus accumbens |
RGD |
PMID:29678771 |
RGD:401851055 |
NCBI chrNW_004936675:1,113,435...1,134,916
Ensembl chrNW_004936675:1,113,435...1,134,910
|
|
G |
Pomc |
proopiomelanocortin |
treatment |
ISO |
|
RGD |
PMID:31329297 |
RGD:405878078 |
NCBI chrNW_004936493:7,060,747...7,065,276
Ensembl chrNW_004936493:7,061,587...7,065,109
|
|
G |
Prl |
prolactin |
|
ISO |
mRNA, protein:increased expression:pituitary gland, blood plasma (rat) mRNA,protein:increased expression:pituitary gland, blood plasma (rat) |
RGD |
PMID:26509893 PMID:28710248 |
RGD:11344152 RGD:401960105 |
NCBI chrNW_004936552:7,204,298...7,212,632
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
Protein:increased expression, increased activity:cerebellum (rat) |
RGD |
PMID:12700235 |
RGD:12801493 |
NCBI chrNW_004936735:1,252,414...1,338,318
Ensembl chrNW_004936735:1,252,414...1,338,323
|
|
G |
Rasgrf1 |
Ras protein specific guanine nucleotide releasing factor 1 |
treatment |
ISO |
|
RGD |
PMID:23763370 |
RGD:13432044 |
NCBI chrNW_004936471:37,173,595...37,278,356
Ensembl chrNW_004936471:37,171,297...37,278,529
|
|
G |
Rps6ka1 |
ribosomal protein S6 kinase A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29109170 |
|
NCBI chrNW_004936474:10,996,867...11,030,504
Ensembl chrNW_004936474:10,996,813...11,030,557
|
|
G |
Setd7 |
SET domain containing 7, histone lysine methyltransferase |
|
ISO |
mRNA:decreased expression:pituitary gland (rat) |
RGD |
PMID:26509893 |
RGD:11344152 |
NCBI chrNW_004936535:8,094,479...8,143,108
Ensembl chrNW_004936535:8,094,178...8,137,580
|
|
G |
Slc25a12 |
solute carrier family 25 member 12 |
treatment |
ISO |
|
RGD |
PMID:23763370 |
RGD:13432044 |
NCBI chrNW_004936509:1,994,082...2,077,731
Ensembl chrNW_004936509:1,990,116...2,077,938
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
ISO |
mRNA:decreased expression:brain (rat) |
RGD |
PMID:26180184 |
RGD:11074449 |
NCBI chrNW_004936538:6,205,268...6,239,062
Ensembl chrNW_004936538:6,205,251...6,239,083
|
|
G |
Tlr4 |
toll like receptor 4 |
ameliorates |
ISO |
|
RGD |
PMID:30312858 |
RGD:405866345 |
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
|
|
G |
Ube3a |
ubiquitin protein ligase E3A |
treatment |
ISO |
|
RGD |
PMID:23763370 |
RGD:13432044 |
NCBI chrNW_004936471:41,187,665...41,290,345
Ensembl chrNW_004936471:41,187,612...41,283,517
|
|
|
G |
Rhoa |
ras homolog family member A |
|
ISO |
protein:increased activation:neuron, cerebellum |
RGD |
PMID:17109064 |
RGD:2298867 |
NCBI chrNW_004936529:1,000,050...1,045,655
Ensembl chrNW_004936529:999,935...1,045,681
|
|
|
G |
Atp5f1e |
ATP synthase F1 subunit epsilon |
|
ISO |
mRNA:decreased expression:heart, mitochondrion (rat) |
RGD |
PMID:21251948 |
RGD:5131501 |
NCBI chrNW_004936530:1,509,605...1,513,033
Ensembl chrNW_004936530:1,509,605...1,513,175
|
|
G |
Atp5po |
ATP synthase peripheral stalk subunit OSCP |
|
ISO |
mRNA:decreased expression:heart, mitochondrion (rat) |
RGD |
PMID:21251948 |
RGD:5131501 |
NCBI chrNW_004936500:8,444,681...8,454,694
Ensembl chrNW_004936500:8,444,546...8,456,048
|
|
G |
Gli1 |
GLI family zinc finger 1 |
|
ISO |
|
RGD |
PMID:25623978 |
RGD:12879410 |
NCBI chrNW_004936646:1,622,308...1,629,787
Ensembl chrNW_004936646:1,622,308...1,629,779
|
|
G |
Shh |
sonic hedgehog signaling molecule |
|
ISO |
|
RGD |
PMID:25623978 |
RGD:12879410 |
NCBI chrNW_004936527:10,033,095...10,042,713
Ensembl chrNW_004936527:10,033,299...10,042,599
|
|
G |
Smo |
smoothened, frizzled class receptor |
treatment |
ISO |
|
RGD |
PMID:24388991 |
RGD:12879411 |
NCBI chrNW_004936579:5,893,064...5,917,021
Ensembl chrNW_004936579:5,892,542...5,917,281
|
|
|
G |
LOC101976500 |
haptoglobin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21075095 |
|
NCBI chrNW_004936475:21,841,054...21,845,821
|
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
treatment |
ISO |
|
RGD |
PMID:28921207 |
RGD:14975164 |
NCBI chrNW_004936470:7,765,810...7,770,837
Ensembl chrNW_004936470:7,765,703...7,768,465
|
|
|
G |
Il16 |
interleukin 16 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:14698845 |
RGD:1354526 |
NCBI chrNW_004936483:19,417,580...19,512,654
Ensembl chrNW_004936483:19,418,086...19,512,639
|
|
|
G |
Daxx |
death domain associated protein |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:17692352 |
RGD:9587799 |
NCBI chrNW_004936476:25,546,091...25,550,390
Ensembl chrNW_004936476:25,546,036...25,550,392
|
|
G |
Kdm3b |
lysine demethylase 3B |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21262293 |
|
NCBI chrNW_004936531:7,517,810...7,600,319
Ensembl chrNW_004936531:7,516,125...7,600,347
|
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
|
RGD |
PMID:20058324 |
RGD:5684396 |
NCBI chrNW_004936482:17,537,697...17,581,320
Ensembl chrNW_004936482:17,538,864...17,581,002
|
|
|
G |
Alad |
aminolevulinate dehydratase |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:decreased activity:blood (rat) |
CTD RGD |
PMID:16597373 PMID:19647414 PMID:21396434 PMID:23792432 PMID:24631795 |
RGD:1599014 RGD:4144142 |
NCBI chrNW_004936559:226,481...237,258
Ensembl chrNW_004936559:226,424...241,684
|
|
G |
Glul |
glutamate-ammonia ligase |
|
ISO |
protein:increased expression:stellate ganglion |
RGD |
PMID:29457680 |
RGD:401794593 |
NCBI chrNW_004936481:7,293,301...7,301,416
Ensembl chrNW_004936481:7,293,091...7,306,202
|
|
G |
Hfe |
homeostatic iron regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20659343 |
|
NCBI chrNW_004936671:1,940,079...1,947,574
Ensembl chrNW_004936671:1,940,101...1,947,580
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16700817 |
|
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
|
|
G |
Mt4 |
metallothionein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19921116 |
|
NCBI chrNW_004936475:8,842,863...8,845,105
Ensembl chrNW_004936475:8,809,813...8,845,137
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
|
RGD |
PMID:28178683 |
RGD:13440092 |
NCBI chrNW_004936475:19,771,384...19,785,034
Ensembl chrNW_004936475:19,769,488...19,785,311
|
|
G |
Qdpr |
quinoid dihydropteridine reductase |
|
ISO |
protein:increased activity:brain, caudate nucleus (rat) |
RGD |
PMID:2359144 |
RGD:5128598 |
NCBI chrNW_004936477:10,687,328...10,708,015
Ensembl chrNW_004936477:10,687,276...10,708,031
|
|
G |
Ryr1 |
ryanodine receptor 1 |
|
ISO |
mRNA:decreased expression:peripheral blood mononuclear cell |
RGD |
PMID:30661027 |
RGD:329812013 |
NCBI chrNW_004936801:1,185,615...1,298,416
Ensembl chrNW_004936801:1,185,733...1,298,289
|
|
G |
Vdr |
vitamin D receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20692022 PMID:23433214 |
|
NCBI chrNW_004936512:5,741,836...5,800,999
Ensembl chrNW_004936512:5,740,748...5,801,109
|
|
G |
Xpo5 |
exportin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28042866 |
|
NCBI chrNW_004936476:16,434,629...16,481,044
Ensembl chrNW_004936476:16,434,638...16,481,044
|
|
G |
Xrcc3 |
X-ray repair cross complementing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23803535 |
|
NCBI chrNW_004936621:1,462,441...1,474,937
Ensembl chrNW_004936621:1,462,428...1,473,868
|
|
|
G |
Alad |
aminolevulinate dehydratase |
|
ISO |
protein:decreased activity:striatum (rat) |
RGD |
PMID:18778733 |
RGD:4144152 |
NCBI chrNW_004936559:226,481...237,258
Ensembl chrNW_004936559:226,424...241,684
|
|
G |
Atp13a2 |
ATPase cation transporting 13A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22285144 |
|
NCBI chrNW_004936474:3,968,216...3,980,821
Ensembl chrNW_004936474:3,968,506...3,980,815
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19442826 |
|
NCBI chrNW_004936486:18,449,371...18,460,435
Ensembl chrNW_004936486:18,448,494...18,455,927
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18041089 |
|
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18041089 |
|
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G |
LOC101961588 |
cytochrome P450 2D17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12171760 |
|
NCBI chrNW_004936718:153,340...157,966
|
|
G |
LOC101966195 |
huntingtin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19845833 |
|
NCBI chrNW_004936477:20,443,101...20,577,167
Ensembl chrNW_004936477:20,443,113...20,577,071 Ensembl chrNW_004936477:20,443,113...20,577,071
|
|
G |
Mfn2 |
mitofusin 2 |
|
ISO |
protein:decreased expression:striatum (rat) |
RGD |
PMID:28232070 |
RGD:12910738 |
NCBI chrNW_004936474:767,754...795,258
Ensembl chrNW_004936474:767,671...796,556
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15010209 PMID:22174044 |
|
NCBI chrNW_004936538:4,052,277...4,097,051
Ensembl chrNW_004936538:4,052,448...4,097,051
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20089134 |
|
NCBI chrNW_004936489:12,118,538...12,913,664
Ensembl chrNW_004936489:12,120,678...13,327,872
|
|
G |
Slc31a1 |
solute carrier family 31 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22465424 |
|
NCBI chrNW_004936559:333,461...364,737
Ensembl chrNW_004936559:331,917...364,852
|
|
G |
Slc39a14 |
solute carrier family 39 member 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28860195 |
|
NCBI chrNW_004939045:1...7,491
|
|
G |
Slc39a8 |
solute carrier family 39 member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29429640 |
|
NCBI chrNW_004936520:961,376...1,036,801
Ensembl chrNW_004936520:962,756...1,037,274
|
|
G |
Snca |
synuclein alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23934647 |
|
NCBI chrNW_004936685:2,077,017...2,175,298
Ensembl chrNW_004936685:2,076,651...2,175,338
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18041089 |
|
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16891999 |
|
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
ISO |
|
RGD |
PMID:18758054 |
RGD:7240571 |
NCBI chrNW_004936529:997,943...999,123
Ensembl chrNW_004936529:998,150...998,987
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
ISO |
protein:decreased activity:plasma |
RGD |
PMID:25975991 |
RGD:401827854 |
NCBI chrNW_004936647:3,904,787...3,914,223
Ensembl chrNW_004936647:3,906,113...3,913,498
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased secretion:serum (rat) |
RGD |
PMID:20508868 |
RGD:4145621 |
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
|
RGD |
PMID:28498799 |
RGD:13439738 |
NCBI chrNW_004936475:19,771,384...19,785,034
Ensembl chrNW_004936475:19,769,488...19,785,311
|
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15515958 |
|
NCBI chrNW_004936522:3,034,364...3,037,632
Ensembl chrNW_004936522:3,035,346...3,036,350
|
|
|
G |
Aqp9 |
aquaporin 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29566083 |
|
NCBI chrNW_004936471:19,321,366...19,361,227
Ensembl chrNW_004936471:19,321,426...19,362,146
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31351185 |
|
NCBI chrNW_004936476:8,621,860...8,625,008
Ensembl chrNW_004936476:8,621,860...8,625,008
|
|
G |
Ins |
insulin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26364587 |
|
NCBI chrNW_004936816:1,002,137...1,003,357
Ensembl chrNW_004936816:1,002,137...1,003,357
|
|
|
G |
Alad |
aminolevulinate dehydratase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21439310 |
|
NCBI chrNW_004936559:226,481...237,258
Ensembl chrNW_004936559:226,424...241,684
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
mRNA:increased expression:hippocampus |
RGD |
PMID:24291742 |
RGD:9588309 |
NCBI chrNW_004936492:696,982...778,132
Ensembl chrNW_004936492:696,960...778,138
|
|
|
G |
Slc6a1 |
solute carrier family 6 member 1 |
|
ISO |
protein:increased expression:brain, synaptosome |
RGD |
PMID:15149801 |
RGD:1643208 |
NCBI chrNW_004936602:2,359,151...2,397,346
Ensembl chrNW_004936602:2,357,607...2,379,061
|
|
|
G |
Ache |
acetylcholinesterase (Cartwright blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:3669600 PMID:8359835 PMID:23000449 |
|
NCBI chrNW_004936543:856,678...862,080
Ensembl chrNW_004936543:856,676...862,109
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:22981459 PMID:22982776 PMID:23044488 PMID:23123253 PMID:23178380 PMID:23220586 PMID:26239905 PMID:31201777 More...
|
|
NCBI chrNW_004936707:1,784,338...1,913,401
Ensembl chrNW_004936707:1,854,444...1,913,460
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
ISO |
|
RGD |
PMID:24188896 |
RGD:10401876 |
NCBI chrNW_004936792:531,076...579,083
Ensembl chrNW_004936792:531,756...579,166
|
|
G |
Pepd |
peptidase D |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:22982776 |
|
NCBI chrNW_004936570:2,315,981...2,431,878
Ensembl chrNW_004936570:2,315,954...2,431,884
|
|
G |
Pon1 |
paraoxonase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:11022865 PMID:20581384 PMID:20981111 PMID:23123254 PMID:24326413 PMID:26340881 PMID:28070599 More...
|
|
NCBI chrNW_004936585:4,954,871...4,979,560
Ensembl chrNW_004936585:4,954,869...4,979,591
|
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
|
ISO |
mRNA, protein:increased expression:hippocampus |
RGD |
PMID:23078219 |
RGD:597805826 |
NCBI chrNW_004936727:1,418,342...1,422,005
Ensembl chrNW_004936727:1,418,799...1,422,147
|
|
G |
Agtr1 |
angiotensin II receptor type 1 |
|
ISO |
|
RGD |
PMID:24814703 |
RGD:10047100 |
NCBI chrNW_004936519:6,831,096...6,873,977
Ensembl chrNW_004936519:6,831,096...6,873,985
|
|
G |
App |
amyloid beta precursor protein |
|
ISO |
protein:increased expression:hippocampus protein:increased expression:plasma |
RGD |
PMID:35317728 |
RGD:597830151 |
NCBI chrNW_004936640:1,549,977...1,787,436
Ensembl chrNW_004936640:1,550,167...1,787,286
|
|
G |
Bdnf |
brain derived neurotrophic factor |
treatment |
ISO |
associated with brain ischemia |
RGD |
PMID:29065194 PMID:29571823 PMID:29599834 PMID:30232930 PMID:32564283 PMID:33324197 PMID:34964700 More...
|
RGD:401959211 RGD:401965400 RGD:401976548 RGD:405850212 RGD:596933096 RGD:596936243 RGD:596936414 |
NCBI chrNW_004936540:5,530,081...5,582,765
Ensembl chrNW_004936540:5,529,942...5,585,014
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
treatment |
ISO |
protein:decreased phosphorylation:hippocampus |
RGD |
PMID:29571823 PMID:36688960 PMID:37736695 |
RGD:401959211 RGD:401959611 RGD:401960090 |
NCBI chrNW_004936631:3,721,307...3,785,346
Ensembl chrNW_004936631:3,721,313...3,780,892
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
treatment |
ISO |
associated with rheumatic heart disease;protein:increased expression:serum protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine |
RGD |
PMID:25251457 PMID:28918204 PMID:29512789 PMID:33324197 PMID:34728231 PMID:36688960 More...
|
RGD:401959611 RGD:405849389 RGD:405850212 RGD:405850250 RGD:405850251 RGD:405866364 |
NCBI chrNW_004936518:4,291,391...4,310,752
Ensembl chrNW_004936518:4,288,154...4,310,753
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
ISO |
mRNA, protein:increased expression:hippocampus |
RGD |
PMID:23078219 |
RGD:597805826 |
NCBI chrNW_004936472:25,236,728...25,246,585
Ensembl chrNW_004936472:25,236,728...25,246,580
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
mRNA:decreased expression:plasma mRNA:decreased expression:hippocampus |
RGD |
PMID:35317728 |
RGD:597830151 |
NCBI chrNW_004936492:11,709,623...11,784,028
Ensembl chrNW_004936492:11,709,222...11,778,351
|
|
G |
Igfbp7 |
insulin like growth factor binding protein 7 |
|
ISO |
protein:increased expression:plasma (human) |
RGD |
PMID:25543030 |
RGD:401960875 |
NCBI chrNW_004936482:19,119,339...19,186,679
Ensembl chrNW_004936482:19,118,321...19,186,685
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
ISO |
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat) |
RGD |
PMID:22959208 PMID:23078219 PMID:29571823 PMID:33390808 |
RGD:401959211 RGD:401965467 RGD:597805826 RGD:7204702 |
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:23077050 |
RGD:8551854 |
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
|
|
G |
Il6 |
interleukin 6 |
treatment |
ISO |
protein:increased expression:hippocampus (rat) |
RGD |
PMID:28684969 PMID:33390808 |
RGD:401965467 RGD:597538492 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Ireb2 |
iron responsive element binding protein 2 |
|
ISO |
protein:increased expression:hippocampus (rat) |
RGD |
PMID:23229539 |
RGD:12904023 |
NCBI chrNW_004936471:36,547,552...36,601,327
Ensembl chrNW_004936471:36,547,500...36,600,636
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
treatment |
ISO |
protein:decreased phosphorylation:hippocampus |
RGD |
PMID:36688960 PMID:37736695 |
RGD:401959611 RGD:401960090 |
NCBI chrNW_004936619:1,889,841...1,932,646
Ensembl chrNW_004936619:1,889,708...1,932,646
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
treatment |
ISO |
protein:decreased phosphorylation:hippocampus |
RGD |
PMID:36688960 PMID:37736695 |
RGD:401959611 RGD:401960090 |
NCBI chrNW_004936501:12,342,670...12,390,650
Ensembl chrNW_004936501:12,384,804...12,392,180
|
|
G |
Ngf |
nerve growth factor |
treatment |
ISO |
associated with brain ischemia |
RGD |
PMID:29599834 PMID:30481505 PMID:34964700 |
RGD:401965395 RGD:401965400 RGD:401976548 |
NCBI chrNW_004936627:635,784...641,290
Ensembl chrNW_004936627:635,788...645,364
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3 group C member 1 |
treatment |
ISO |
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus |
RGD |
PMID:28086911 PMID:36637480 |
RGD:408345237 RGD:408364984 |
NCBI chrNW_004936504:10,960,069...11,056,834
Ensembl chrNW_004936504:10,959,192...11,056,856
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3 group C member 2 |
|
ISO |
protein:increased expression:hippocampus (rat) |
RGD |
PMID:33390808 |
RGD:401965467 |
NCBI chrNW_004936535:1,139,687...1,467,469
Ensembl chrNW_004936535:1,140,178...1,467,471
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
treatment |
ISO |
|
RGD |
PMID:29065194 PMID:30232930 PMID:32564283 |
RGD:596933096 RGD:596936243 RGD:596936414 |
NCBI chrNW_004936680:267,850...621,467
Ensembl chrNW_004936680:267,596...615,928
|
|
G |
Tlr2 |
toll like receptor 2 |
treatment |
ISO |
|
RGD |
PMID:28684969 PMID:32300366 |
RGD:597538486 RGD:597538492 |
NCBI chrNW_004936576:522,234...531,660
Ensembl chrNW_004936576:527,434...529,788
|
|
G |
Tlr4 |
toll like receptor 4 |
treatment |
ISO |
|
RGD |
PMID:28684969 PMID:32300366 |
RGD:597538486 RGD:597538492 |
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO |
protein:increased expression:hippocampus (rat) mRNA, protein:increased expression:hippocampus |
RGD |
PMID:23078219 PMID:29571823 PMID:33390808 |
RGD:401959211 RGD:401965467 RGD:597805826 |
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
ISO |
protein:increased expression:lung, skin, plasma |
RGD |
PMID:24831016 |
RGD:11341687 |
NCBI chrNW_004936537:4,637,028...4,647,915
Ensembl chrNW_004936537:4,636,667...4,647,916
|
|
|
G |
Ache |
acetylcholinesterase (Cartwright blood group) |
disease_progression |
ISO |
|
RGD |
PMID:8043620 |
RGD:405855847 |
NCBI chrNW_004936543:856,678...862,080
Ensembl chrNW_004936543:856,676...862,109
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
|
ISO |
mRNA, protein:increased expression:hippocampal formation, amygdala |
RGD |
PMID:27760517 |
RGD:405850209 |
NCBI chrNW_004936480:5,042,531...5,047,157
Ensembl chrNW_004936480:5,043,204...5,044,472
|
|
G |
Tph2 |
tryptophan hydroxylase 2 |
|
ISO |
mRNA:increased expression:hippocampus, prefrontal cortex |
RGD |
PMID:36750928 |
RGD:597805905 |
NCBI chrNW_004936568:974,575...1,065,800
Ensembl chrNW_004936568:974,767...1,065,804
|
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20799992 |
|
NCBI chrNW_004936619:597,970...618,564
Ensembl chrNW_004936619:608,441...616,779
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21041608 |
|
NCBI chrNW_004936621:620,163...639,115
Ensembl chrNW_004936621:620,074...639,093
|
|
G |
Camk2b |
calcium/calmodulin dependent protein kinase II beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17603807 |
|
NCBI chrNW_004936478:19,183,493...19,278,457
Ensembl chrNW_004936478:19,180,726...19,278,920
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19386276 |
|
NCBI chrNW_004936489:4,616,839...4,887,179
Ensembl chrNW_004936489:4,614,754...4,887,171
|
|
G |
Grm2 |
glutamate metabotropic receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20211215 |
|
NCBI chrNW_004936529:3,042,220...3,053,670
Ensembl chrNW_004936529:3,042,248...3,053,673
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15729709 |
|
NCBI chrNW_004936599:2,197,681...2,200,642
Ensembl chrNW_004936599:2,197,634...2,201,050
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19747927 |
|
NCBI chrNW_004936480:5,042,531...5,047,157
Ensembl chrNW_004936480:5,043,204...5,044,472
|
|
G |
Htr6 |
5-hydroxytryptamine receptor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20705401 |
|
NCBI chrNW_004936474:5,848,719...5,858,520
Ensembl chrNW_004936474:5,848,707...5,859,749
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17196621 |
|
NCBI chrNW_004936541:4,157,847...4,178,156
Ensembl chrNW_004936541:4,157,393...4,178,177
|
|
G |
Npy1r |
neuropeptide Y receptor Y1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19566775 |
|
NCBI chrNW_004936555:2,267,727...2,276,673
Ensembl chrNW_004936555:2,267,669...2,276,778
|
|
G |
Oprm1 |
opioid receptor mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16402083 |
|
NCBI chrNW_004936489:6,506,207...6,567,136
Ensembl chrNW_004936489:6,506,207...6,548,946
|
|
G |
Phb1 |
prohibitin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18504422 |
|
NCBI chrNW_004936490:12,127,065...12,138,870
Ensembl chrNW_004936490:12,127,065...12,138,870
|
|
G |
Pick1 |
protein interacting with PRKCA 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17606663 |
|
NCBI chrNW_004936492:3,098,196...3,115,921
Ensembl chrNW_004936492:3,097,629...3,116,526
|
|
G |
Rgs9 |
regulator of G protein signaling 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17318883 |
|
NCBI chrNW_004936541:7,472,195...7,525,220
Ensembl chrNW_004936541:7,458,539...7,525,220
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12931138 |
|
NCBI chrNW_004936815:359,775...400,690
Ensembl chrNW_004936815:359,775...400,690
|
|
G |
Snca |
synuclein alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15542733 |
|
NCBI chrNW_004936685:2,077,017...2,175,298
Ensembl chrNW_004936685:2,076,651...2,175,338
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16807759 |
|
NCBI chrNW_004936489:11,178,338...11,191,601
Ensembl chrNW_004936489:11,178,015...11,191,781
|
|
|
G |
Drd3 |
dopamine receptor D3 |
|
ISO |
associated with schizophrenia |
RGD |
PMID:12960753 |
RGD:1581250 |
NCBI chrNW_004936536:1,580,732...1,616,726
Ensembl chrNW_004936536:1,580,732...1,616,725
|
|
G |
LOC101969421 |
cytochrome P450 1A2 |
treatment |
ISO |
associated with schizophrenia |
RGD |
PMID:10889552 |
RGD:1358545 |
NCBI chrNW_004936471:33,704,616...33,709,455
Ensembl chrNW_004936471:33,703,792...33,709,484
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
associated with schizophrenia |
RGD |
PMID:12960753 |
RGD:1581250 |
NCBI chrNW_004936489:11,178,338...11,191,601
Ensembl chrNW_004936489:11,178,015...11,191,781
|
|
|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
susceptibility |
ISO |
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:SNP: 3435T>C(human) Multidrug resistance 1, ABCB1-related CTD Direct Evidence: marker/mechanism |
RGD OMIA CTD |
PMID:1917657 PMID:2345955 PMID:2475964 PMID:3592367 PMID:6368862 PMID:7768734 PMID:8647944 PMID:10803640 PMID:11692082 PMID:11939306 PMID:12352921 PMID:12559367 PMID:12774979 PMID:14627096 PMID:14765742 PMID:15289602 PMID:15305851 PMID:15932411 PMID:15975717 PMID:16327220 PMID:16343287 PMID:16594604 PMID:16984822 PMID:17199425 PMID:17644437 PMID:17803743 PMID:17877579 PMID:17938643 PMID:18299336 PMID:18557525 PMID:18605373 PMID:18795852 PMID:18922637 PMID:19152588 PMID:19171022 PMID:19733104 PMID:20043790 PMID:20391637 PMID:20655253 PMID:21113104 PMID:21488961 PMID:22039792 PMID:22329447 PMID:22362942 PMID:22735986 PMID:24302812 PMID:24332606 PMID:26153274 PMID:27387721 PMID:27525650 PMID:28061549 PMID:30020547 PMID:30139545 PMID:31032534 PMID:31113564 PMID:31555677 PMID:31685133 PMID:31711409 PMID:31743433 PMID:35017851 PMID:35536118 PMID:36037240 PMID:36326478 PMID:36786530 PMID:36924353 PMID:37475133 PMID:37582787 PMID:37990577 More...
|
RGD:11081146 |
NCBI chrNW_004936763:1,225,355...1,308,257
Ensembl chrNW_004936763:1,226,482...1,297,427
|
|
G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29604313 |
|
NCBI chrNW_004936672:3,461,387...3,468,053
Ensembl chrNW_004936672:3,460,383...3,468,255
|
|
G |
Add3 |
adducin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19784758 |
|
NCBI chrNW_004936486:928,956...1,042,168
Ensembl chrNW_004936486:928,522...1,043,084
|
|
G |
Adra1b |
adrenoceptor alpha 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19125850 |
|
NCBI chrNW_004936515:3,523,799...3,572,467
Ensembl chrNW_004936515:3,523,797...3,572,596
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19784758 |
|
NCBI chrNW_004936472:25,477,094...25,502,823
Ensembl chrNW_004936472:25,477,010...25,502,840
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21620937 |
|
NCBI chrNW_004936707:1,784,338...1,913,401
Ensembl chrNW_004936707:1,854,444...1,913,460
|
|
G |
Bcl2l1 |
BCL2 like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19784758 |
|
NCBI chrNW_004936485:18,654,046...18,707,324
|
|
G |
Casp3 |
caspase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21972528 |
|
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
Cat |
catalase |
|
ISO |
protein:decreased activity:serum: |
RGD |
PMID:16938375 |
RGD:9068882 |
NCBI chrNW_004936533:3,601,270...3,637,128
Ensembl chrNW_004936533:3,600,955...3,637,422
|
|
G |
Cck |
cholecystokinin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19784758 |
|
NCBI chrNW_004936695:2,776,705...2,782,280
Ensembl chrNW_004936695:2,776,831...2,782,061
|
|
G |
Cd3d |
CD3d molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19784758 |
|
NCBI chrNW_004936542:3,400,129...3,403,628
Ensembl chrNW_004936542:3,399,845...3,403,634
|
|
G |
Crispld2 |
cysteine rich secretory protein LCCL domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19784758 |
|
NCBI chrNW_004936641:3,228,791...3,277,379
Ensembl chrNW_004936641:3,228,762...3,277,427
|
|
G |
Drd2 |
dopamine receptor D2 |
|
ISO |
mRNA:decreased expression:hippocampus (rat) |
RGD |
PMID:19576243 |
RGD:2311553 |
NCBI chrNW_004936612:1,094,686...1,154,149
Ensembl chrNW_004936612:1,094,680...1,154,798
|
|
G |
Egln1 |
egl-9 family hypoxia inducible factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29471019 |
|
NCBI chrNW_004936484:19,343,770...19,386,087
|
|
G |
Epha4 |
EPH receptor A4 |
|
ISO |
|
RGD |
PMID:10336070 |
RGD:5688752 |
NCBI chrNW_004936569:3,539,269...3,670,322
Ensembl chrNW_004936569:3,540,053...3,670,348
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
susceptibility |
ISO |
DNA:missense mutation:cds:p.H139R (human) |
RGD |
PMID:17022435 |
RGD:5490249 |
NCBI chrNW_004936526:2,589,254...2,652,831
Ensembl chrNW_004936526:2,614,059...2,653,286
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19220411 |
|
NCBI chrNW_004936488:4,384,710...4,388,118
Ensembl chrNW_004936488:4,384,705...4,388,122
|
|
G |
Gabrr2 |
gamma-aminobutyric acid type A receptor subunit rho2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19784758 |
|
NCBI chrNW_004936510:2,891,136...2,949,428
Ensembl chrNW_004936510:2,891,101...2,951,071
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
susceptibility |
ISO |
DNA:polymorphism: : |
RGD |
PMID:17022435 |
RGD:5490249 |
NCBI chrNW_004936599:2,197,681...2,200,642
Ensembl chrNW_004936599:2,197,634...2,201,050
|
|
G |
Igf1r |
insulin like growth factor 1 receptor |
|
ISO |
DNA: snp: intron: rs1879612: bortezomib induced |
RGD |
PMID:20864405 |
RGD:5686413 |
NCBI chrNW_004936483:4,563,995...4,860,231
Ensembl chrNW_004936483:4,564,512...4,852,925
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:23916895 |
RGD:7364985 |
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G |
Lat |
linker for activation of T cells |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19784758 |
|
NCBI chrNW_004936501:11,759,245...11,764,693
Ensembl chrNW_004936501:11,760,840...11,764,397
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16955484 |
|
NCBI chrNW_004936474:158,376...282,310
Ensembl chrNW_004936474:157,590...282,342
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20211941 |
|
NCBI chrNW_004936509:6,589,967...6,621,171
Ensembl chrNW_004936509:6,590,630...6,620,262
|
|
G |
Nlrp3 |
NLR family pyrin domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32014472 |
|
NCBI chrNW_004936864:709,693...732,119
Ensembl chrNW_004936864:709,709...731,718
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20849151 |
|
NCBI chrNW_004936475:19,771,384...19,785,034
Ensembl chrNW_004936475:19,769,488...19,785,311
|
|
G |
P2rx1 |
purinergic receptor P2X 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19784758 |
|
NCBI chrNW_004936677:530,338...546,742
Ensembl chrNW_004936677:530,330...548,180
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19442825 |
|
NCBI chrNW_004936785:476,200...503,371
Ensembl chrNW_004936785:476,078...503,321
|
|
G |
Pon1 |
paraoxonase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21329748 |
|
NCBI chrNW_004936585:4,954,871...4,979,560
Ensembl chrNW_004936585:4,954,869...4,979,591
|
|
G |
Prkcd |
protein kinase C delta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22512859 |
|
NCBI chrNW_004936473:3,892,625...3,923,467
Ensembl chrNW_004936473:3,892,366...3,923,515
|
|
G |
Ptges3 |
prostaglandin E synthase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29471019 |
|
NCBI chrNW_004936646:969,674...990,532
|
|
G |
Rnase6 |
ribonuclease A family member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19784758 |
|
NCBI chrNW_004936880:78,532...79,342
Ensembl chrNW_004936880:78,081...79,021
|
|
G |
Slc18a2 |
solute carrier family 18 member A2 |
|
ISO |
protein:increased expression:thalamus (rat) |
RGD |
PMID:19798748 |
RGD:5130970 |
NCBI chrNW_004936486:7,075,373...7,108,984
Ensembl chrNW_004936486:7,075,358...7,109,637
|
|
G |
Srsf5 |
serine and arginine rich splicing factor 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19784758 |
|
NCBI chrNW_004936495:12,952,610...12,957,640
Ensembl chrNW_004936495:12,952,646...12,960,681
|
|
G |
St8sia1 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19784758 |
|
NCBI chrNW_004936548:4,671,257...4,797,917
Ensembl chrNW_004936548:4,671,284...4,796,426
|
|
G |
Tgm1 |
transglutaminase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19784758 |
|
NCBI chrNW_004936722:292,999...306,540
Ensembl chrNW_004936722:292,143...306,572
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19784758 |
|
NCBI chrNW_004936492:6,996,627...7,046,137
Ensembl chrNW_004936492:6,996,613...7,046,190
|
|
|
G |
Uts2 |
urotensin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16160878 |
|
NCBI chrNW_004936623:2,339,259...2,345,717
Ensembl chrNW_004936623:2,340,778...2,345,700
|
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO |
protein:increased expression:mammillary body |
RGD |
PMID:1650797 |
RGD:407572523 |
NCBI chrNW_004936493:7,060,747...7,065,276
Ensembl chrNW_004936493:7,061,587...7,065,109
|
|